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ABSTRACT
The Roles of Phosducin-Like Protein 1 and Programmed Cell Death Protein 5 as
Molecular Co-Chaperones of the Cytosolic Chaperonin Complex
Christopher M. Tracy
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
A fundamental question in biology is how proteins, which are synthesized by the
ribosome as a linear sequence of amino acids, fold into their native functional state. Many
proteins require the assistance of molecular chaperones to maneuver through the folding process
to protect them from aggregation and to help them reach their native state in the very
concentrated protein environment of the cell. This study focuses on the roles of Phosducin-like
Protein 1 (PhLP1) and Programmed Cell Death Protein 5 (PDCD5) as molecular co-chaperones
of the Cytosolic Chaperonin Complex (CCT).
Signaling in retinal photoreceptors is mediated by canonical G protein pathways.
Previous in vitro studies have demonstrated that Gβ subunits rely on CCT and its co-chaperone
PhLP1 to fold and assemble into Gβγ and RGS-Gβ5 heterodimers. The importance of PhLP1 in
the assembly process was first demonstrated in vivo in a retinal rod photoreceptor-specific
deletion of PhLP1. To test whether this mechanism applied to other cell types, we prepared a
second mouse line that specifically disrupts the PhLP1 gene in cone photoreceptor cells and
measured the effects on G-protein expression and cone visual signal transduction. In PhLP1
depleted cones, Gt2 and RGS9-Gβ5 levels were dramatically reduced, resulting a 60-fold decrease
in cone sensitivity and a 50-fold increase in cone photoresponse recovery time. These results
demonstrate a common mechanism of Gβγ and RGS9-Gβ5 assembly in rods and cones,
underlining the significance of PhLP1/CCT-mediated folding in G protein signaling.
PDCD5 has been proposed to act as a pro-apoptotic factor and tumor suppressor.
However, the mechanisms underlying its apoptotic function are largely unknown. A proteomics
search for PhLP1 binding partners revealed a robust interaction between PDCD5 and CCT.
PDCD5 formed a complex with CCT and β-tubulin, a key CCT folding substrate, and
specifically inhibited β-tubulin folding. Cryo-electron microscopy studies of the PDCD5-CCT
complex suggested a possible mechanism of inhibition of β-tubulin folding. PDCD5 binds the
apical domain of the CCTβ subunit, projecting above the folding cavity without entering it. Like
PDCD5, β-tubulin also interacts with the CCTβ apical domain, but a second site is found at the
sensor loop deep within the folding cavity. These orientations of PDCD5 and β-tubulin suggest
that PDCD5 sterically interferes with β-tubulin binding to the CCTβ apical domain and inhibits
β-tubulin folding. Given the importance of tubulins in cell division and proliferation, PDCD5
might exert its apoptotic function at least in part through inhibition of β-tubulin folding.

Key words: Chaperonin, chaperone, G-protein signaling, phosducin-like protein, CCT, PhLP1,
PDCD5, apoptosis
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CHAPTER 1:
CHAPERONE-MEDIATED ASSEMBLY OF G-PROTEIN COMPLEXES
Summary
*

G protein signaling depends on the ability of the individual subunits of the G protein

heterotrimer to assemble into functional complexes. Formation of the G protein βγ (Gβγ) dimer
is particularly challenging because it is an obligate dimer in which the individual subunits are
unstable on their own. Recent studies have revealed an intricate chaperone system that brings the
Gβ and Gγ subunits together. This system includes the cytosolic chaperonin containing TCP-1
(CCT) and its co-chaperone phosducin-like protein 1 (PhLP1). CCT assists Gβ in achieving its βpropeller structure, while PhLP1 releases Gβ from CCT and facilitates its interaction with Gγ.
Once Gβγ is formed, PhLP1 remains bound until it is displaced by the Gα subunit and the G
protein heterotrimer is brought together. Another obligate dimer is the complex between the G
protein β5 subunit and a regulator of G protein signaling protein (RGS-Gβ5). RGS-Gβ5 also
requires CCT for Gβ5 folding, but PhLP1 plays a different role. It stabilizes the interaction
between Gβ5 and CCT, perhaps to increase folding efficiency. After Gβ5 folding PhLP1 must
subsequently release, allowing the RGS protein to bind and form the RGS-Gβ5 dimer directly on
CCT. RGS-Gβ5 is then freed from CCT to interact with its membrane anchoring protein and
form a stable complex that turns off the G protein signal by catalyzing GTP hydrolysis on Gα.
Introduction
A fundamental question in biology is how proteins, which are synthesized by the
ribosome as a linear sequence of amino acids, fold into their native functional state. It is now
*

This chapter is a published review written by Dr. Willardson and me:
1.
Willardson, B., and Tracy, C. (2012) Chaperone-Mediated Assembly of G Protein Complexes. in GPCR
Signalling Complexes – Synthesis, Assembly, Trafficking and Specificity (Dupré, D. J., Hébert, T. E., and Jockers, R.
eds.), Springer Netherlands. pp 131-153
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clear that many proteins require the assistance of molecular chaperones to maneuver through the
folding process. Molecular chaperones are themselves proteins that protect newly synthesized or
unfolded proteins from aggregation and help them reach their native state in the very
concentrated protein environment of the cell (2).
Chaperonins
One important class of molecular chaperones is the chaperonins. Chaperonins are large,
multi-subunit complexes that form stacked, double-ring structures with a central cavity in each
ring. These cavities provide an isolated environment for client proteins to bind and fold (3,4).
Each subunit consists of three domains: an equatorial domain that binds and hydrolyzes ATP, an
apical domain that binds substrates, and an intermediate domain that connects the two other
domains and facilitates inter-domain communication (4). There are two types of chaperonins.
Group I chaperonins are found in bacteria (i.e. GroEL from E. coli), mitochondria and
chloroplasts (Hsp60). Their ring structures are composed of seven identical subunits that bind
and hydrolyze ATP. ATP binding is coordinated with encapsulation of substrates within the
folding cavity by a small co-chaperone called GroES in E. coli and Hsp10 in eukaryotes (2,3).
The group II chaperonins are found in archeabacteria (named thermosomes) and in the
eukaryotic cytosol (termed CCT, cytosolic chaperonin containing tailless complex polypeptide 1,
also called TRiC). CCT is the most complex of all the chaperonins, with each of the two rings
composed of eight paralogous subunits that orchestrate the folding of many proteins, with the
most abundant substrates being actins and tubulins (4). In fact, CCT is required for folding 915% of all newly synthesized cytosolic proteins in the cell. CCT substrates tend to have complex
domain topologies and range up to ~70 kDa in size (5,6). Nascent polypeptides or denatured
proteins bind inside the folding cavity to regions of both the equatorial and apical domains of the
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CCT subunits (7). The process of ATP binding and hydrolysis induces dramatic conformational
changes in the apical domains that result in closure of the folding cavity by finger-like helical
extensions found at the tip of the apical domains (8-13). The conformational change also exposes
a more hydrophilic surface on the inside of the cavity (8,9). The substrate then folds in this
sequestered environment. After phosphate release from the nucleotide-binding pocket, the apical
domains reopen and the folded protein dissociates from CCT. If the protein has not yet reached
its native structure, it can reassociate for another round of ATP binding and hydrolysis (8,9,1113).
CCT substrates often require additional proteins called co-chaperones for efficient
delivery or release from CCT. For example, the co-chaperone prefoldin is required for transfer of
nascent actin or tubulin to CCT (14,15). The unfolded actin or tubulin binds to hydrophobic
residues at the tips of the tentacle-like extensions of prefoldin (14). The complex then binds and
transfers the nascent substrate to CCT to continue folding (14,16,17). Another CCT cochaperone is Heat-shock Protein 70 (Hsp70), which besides acting as a chaperone on its own,
can transfer different substrates to the chaperonin for more efficient folding (18). Co-chaperones
can also mediate the release of proteins from CCT once they have completed folding. Phosducinlike Protein 1 (PhLP1) serves such a purpose in stably releasing the β subunit of the G-protein
from CCT and thus plays a critical role in all of G protein signaling.
G Protein Signaling
Cells detect and respond to a myriad of extracellular signals via seven-transmembrane G
protein-coupled receptors (GPCR) and their associated G protein signaling pathways (19). The
list of molecules that transmit signals through GPCRs is impressive, including hormones,
neurotransmitters, chemokines and sensory molecules such as odorants and tastants. Even
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photons of light are detected by GPCRs and converted into a neural response by a G protein
pathway in the photoreceptor cells of the retina (20). Such diverse signaling requires a large
array of receptors, as seen by the nearly 900 genes encoding different GPCRs in humans (21).
The importance of G protein signaling to human physiology is evidenced by the fact that GPCRs
are the target of one third of currently marketed drugs (22).
The basic architecture of G protein signaling pathways is shown in Figure 1-1 (23-27).
The pathway is initiated by the binding of the signaling molecule on the extracellular surface of
the GPCR. This interaction causes a conformational change in the receptor which opens up its
seven helical bundles on the intracellular surface, exposing the binding site for the G protein
(28,29). In its inactive form, the G protein is a heterotrimer of α, β and γ subunits with GDP
bound to the nucleotide binding site on the Gα subunit (25,30). Binding to the activated receptor
releases GDP from Gα, allowing GTP to replace GDP in the nucleotide binding site (24). The
extra phosphate of GTP induces a conformational change that disrupts the interaction of Gα with
the Gβγ subunits, causing the dissociation of Gα-GTP from Gβγ (31,32). Gα-GTP is then free to
interact with effector enzymes such as adenylyl cyclase, phospholipase Cβ or Rho guanine
nucleotide exchange factors and regulate their activity (33). The Gβγ pair is an obligate dimer
that remains together throughout its lifetime in the cell (34). Like Gα, Gβγ binds effectors
enzymes (35-38) but can also interact with ion channels such as inwardly-rectifying K+ channels
(39,40) and voltage-gated Ca2+ channels (41,42). The changes in activity of effector enzymes and
ion channels lead to changes in the cellular concentration of second messengers such as cyclic
nucleotides and Ca2+ as well as variations in the plasma membrane potential. These changes then
drive the cellular response to the signal. The signal is turned off by the action of regulators of G
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Figure 1-1. The G protein signaling cycle. The scheme depicts the G protein activation/inactivation cycle using
the atomic structures of the individual components determined by X-ray crystallography. The entire cycle occurs
on the plasma membrane with all components associated with the inner leaflet of the plasma membrane, or
spanning the membrane in the case of the GPCR, and is only shown displaced from the membrane for clarity
purposes. See text for a description of the cycle. Color code for the proteins is: GPCR – green, Gα – teal, Gβ1 –
blue, Gγ – red, RGS DEP/DHEX domain – pink, Gβ5 – dark blue, RGS Gγ-like domain – dark red, RGS domain
– orange. PDB numbers for the various structures are: GPCR-G protein complex (3SN6) (24), G protein
heterotrimer (1GOT) (25), Gα-GTP (1TND) (26), Gβ5-RGS (1PB1) (27).

protein signaling (RGS) proteins that catalyze the hydrolysis of GTP to GDP on Gα, allowing the
reassociation of Gα-GDP with Gβγ and returning the system to its inactive state (43).
In order for GPCRs, G proteins and effectors to perform these functions, they must first
be synthesized, and their nascent chains must find their binding partners and move to the plasma
membrane where the initial signaling events occur. Of the many diseases associated with
malfunctions in G protein pathways, an important subset results from misfolding mutations in
GPCRs or other pathway components that disrupt trafficking of the GPCR and assembly of the G
protein and effector complexes (44-49). Thus, it has become increasingly important to
5

understand the folding pathways of the receptors and other components of the G protein
pathway.
Assembly of the Gβγ Dimer
A particularly puzzling problem regarding the folding and assembly of G protein
signaling components is how obligate oligomers such as the Gβγ dimer associate when the
individual protomers of these protein complexes are not stable on their own. The protomers
cannot simply wait after they have been synthesized by the ribosome for a random interaction
with their binding partners to form a stable complex. This dilemma has been considered for some
time for the Gβγ complex. Once formed, the dimer is very stable, but by itself the Gβ subunit is
not (50). How then could the complex ever form if Gβ cannot fold into a stable structure on its
own? Higgins and Casey in an early study of Gβγ assembly postulated that Gβ might require
accessory proteins to associate with Gγ (50). Interestingly, Gβγ dimers could be formed in rabbit
reticulocyte lysate (51) and in insect cells (50) where heterotrimeric G proteins are normally
expressed, but not in bacteria where they are not (50), suggesting that any accessory proteins
may have co-evolved with the G proteins to assemble the Gβγ dimer. It was some time later
before additional clues began to surface and shed light on the mechanism of Gβγ assembly.
The first clues came from genetic studies of G protein signaling in the chestnut blight
fungus C. parasitica in which disruption of a gene termed bdm1 gave the exact same phenotype
as disruption of the Gβ gene (52). This observation was interesting because the bdm1 gene was
homologous to phosducin, a known binding partner of Gβγ in mammalian photoreceptors.
However, the absolute requirement for bdm1 in G protein signaling in C. parasitica was
inconsistent with the proposed role of phosducin in photoreceptors, which was to inhibit G
protein signaling by binding Gβγ and blocking its interaction with Gα (53). Bdm1 is actually a
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closer homolog of PhLP1, a member of the phosducin gene family with 65% homology to
phosducin (54). PhLP1 also binds Gβγ like phosducin (55), but its expression pattern is very
different, being found in most tissues and cell types, while phosducin is limited principally to
photoreceptors (56). A breakthrough in this quandary came when our lab discovered that PhLP1
was a binding partner for the cytosolic chaperonin CCT (57). Our data suggested that PhLP1 was
not a client protein of CCT, but a binding partner that bound above the folding cavity at the tips
of the apical domains, similar to how GroES binds GroEL, leaving room within the protein
cavity for a client protein (57,58). Although indirect, this finding was the first link between Gβγ
and the protein chaperone system.
Chaperone-mediated Assembly of G protein complexes
While our work on the interaction between PhLP1 and CCT was on-going, several
studies suggested that WD40 repeat proteins like Gβ were important CCT clients. A proteomic
analysis of protein-protein interactions in yeast showed several interactions between yeast CCT
and proteins containing WD40 repeats (59,60). WD40 repeats fold into β-propeller structures
(30,61), a ring of β-sheets that often requires assistance from chaperones to correctly fold (6).
Furthermore, several of these WD40 repeat proteins were found to require CCT for their folding
(15,62). With the backdrop of these findings, a second genetic study, this time in Dictyoselium,
shed further light on the issue. Like the previous genetic study, this work reported that genetic
deletion of PhLP1 phenocopied a Gβ deletion (63). G protein signaling in these cells was lost in
the absence of PhLP1 (63). Importantly, Gβ and Gγ could be expressed in the absence of PhLP1,
but they did not associate with the plasma membrane as in the wild-type, suggesting that they
were not forming Gβγ dimers (63). Putting all of this data together indicated to us that PhLP1
might be involved in Gβ folding and assembly with Gγ. We tested this hypothesis by measuring
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the effects of siRNA-mediated depletion of PhLP1 in HEK-293 cells on the formation of nascent
Gβγ dimers in a pulse-chase experimental format. A 70% knockdown of PhLP1 caused a 5-fold
decrease in the rate of Gβγ assembly (64). Moreover, over-expression of an N-terminal
truncation of PhLP1 completely blocked Gβγ assembly (64). This truncation was missing an
important Gβ interaction site in helix 1 of PhLP1 (65), creating a variant that bound Gβγ poorly
but still bound CCT well. As a result, the variant could displace endogenous PhLP1 from CCT,
but without the ability to bind Gβ, it could not assist in Gβγ assembly. Thus, this PhLP1 variant
was acting as a potent dominant negative inhibitor of Gβγ assembly. These experiments were
consistent with our hypothesis that PhLP1 played an important role in Gβγ assembly and were
supported by results from other labs using different experimental approaches (66,67).
Subsequent studies began to shed light on the mechanism by which PhLP1 assists in Gβγ
assembly. Wells et al. showed that nascent Gβ bound CCT and was released in the presence of
ATP and Gγ to form nascent Gβγ dimers, but no association of Gγ with CCT was observed,
suggesting that Gβ was released from CCT upon association with Gγ (68). In a separate study,
we found that PhLP1 and Gβ formed a ternary complex with CCT (69), and the stability of this
complex was determined by protein kinase CK2 phosphorylation of PhLP1 at a unique triple
serine sequence near the N-terminus (S18-20) (69). If S18-20 was phosphorylated, the ternary
complex was short-lived, PhLP1 and Gβ were released from CCT and Gβγ dimers were
formed (69). Maximal Gβγ assembly activity required two or three phosphorylation events
within the S18-20 sequence (69). If S18-20 was not phosphorylated the complex was stable,
PhLP1 and Gβ were not released from CCT and Gβγ dimer formation was severely impaired
(69). Thus, CK2 phosphorylation of PhLP1 triggers the release of Gβ from CCT, allowing its
association with Gγ (69).
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From these results, a model for PhLP1-mediated Gβγ assembly can be put forward
(Figure 1-2A) (70). In this model, nascent Gβ associates with CCT shortly after its synthesis on
the ribosome. The process by which nascent Gβ is delivered to CCT has not been studied. One
possibility is that co-translational chaperones of the Hsp70 and Hsp40 families bind the nascent
Gβ during its synthesis and then transfer the nascent chain to CCT. Such a relay system of
chaperones has been described for other proteins (71). Another possibility is that CCT accepts
the nascent Gβ chain directly from the ribosome during synthesis. Direct binding of nascent
chains to CCT has been observed previously for actin (72). Whatever the mechanism of delivery
to CCT, once Gβ binds it is then folded by CCT. Recent cryo-EM studies of the Gβ-CCT
intermediate from Jose Valpuesta’s lab indicate that Gβ achieves a near native conformation
within the folding cavity (73). However, unlike other CCT substrates that are released once they
have achieved a stable fold, Gβ does not release from CCT in the absence of PhLP1 (69). The

Figure 1-2. Effects of PhLP1 deletion on Gβγ and RGS9-Gβ5 assembly. A, B, The scheme summarizes the
proposed mechanisms for G-protein heterotrimer (A) and R9AP/RGS9-Gβ5 assembly (B) and the effects of PhLP1
deletion on the assembly process (shown in red). Reprinted from (70)
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inability to release most likely stems from the fact that the Gβ β-propeller is unstable on its own.
The role of PhLP1 may be to bind and stabilize the β-propeller, thereby reducing the contacts
between Gβ and CCT and facilitating release.
Role of PhLP1 phosphorylation in Gβγ assembly
Another unresolved question in this model is why phosphorylation of PhLP1 is required
for Gβ release from CCT. CK2 phosphorylation does not affect PhLP1 binding to Gβγ, however
it does increase the binding of PhLP1 to CCT significantly in the absence of Gβ (69). This
increase in binding upon PhLP1 phosphorylation seems contrary to the observed increase in the
rate of release of PhLP1-Gβ from CCT upon PhLP1 phosphorylation (69). A possible
explanation could be that phosphorylation changes the orientation of PhLP1 on CCT. The basis
of this notion comes from cryo-EM studies of the PhLP1-CCT complex. Unphosphorylated
PhLP1 bound CCT in two different orientations, one in which the N-terminal domain of PhLP1
was oriented toward the CCTα subunit and a second in which it was oriented toward the CCTβ
subunit (58). The first orientation was favored, being populated by two-thirds of the complexes.
However, the cryo-EM structure of PhLP1-Gβ-CCT shows Gβ bound to CCTβ within the
folding cavity and PhLP1 sitting above Gβ, spanning the cavity (73). Thus, to effectively interact
with Gβ, PhLP1 must be oriented toward CCTβ in the second conformation. Perhaps
phosphorylation favors the second orientation and puts PhLP1 in position to bind Gβ. Once
bound, both PhLP1 and Gβ could lose contacts with CCT and subsequently release from the
chaperonin. Additional structural studies of both phosphorylated and unphosphorylated PhLP1
bound to CCT will be needed to test this possibility.
It is currently unclear whether CK2 phosphorylation of PhLP1 is regulated. CK2 is a
constitutively active kinase which is controlled only by its expression levels and the proximity of
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its many substrates, which in turn is determined by its subcellular localization and the complexes
in which it participates (74). Thus, it is possible that PhLP1 is constitutively phosphorylated and
the unphosphorylated form is rare. Fortunately, this possibility can be readily tested because the
phosphorylation status of PhLP1 is easily measured by following the decrease in the mobility of
PhLP1 in SDS-PAGE that occurs upon CK2 phosphorylation at S18-20 (69,75). In HEK-293
cells, mouse embryonic tissue and mouse heart, PhLP1 was 100% phosphorylated at S18-20,
while it was 70-80% phosphorylated in mouse brain and 10-20% phosphorylated in mouse
adrenal gland (75). These results suggest that CK2 phosphorylation of PhLP1 S18-20 is
regulated differently in different tissues and might be a means of controlling the rate of Gβγ
assembly.
Mechanism of Gβ association with Gγ
The model of Figure 1-2 predicts that Gβ is released from CCT in a complex with PhLP1
prior to its interaction with Gγ. There are several observations that support this idea. First,
nascent Gβ was shown by co-immunoprecipitation to form a complex with PhLP1 that did not
contain Gγ (64). Thus, nascent Gβ must be binding PhLP1 prior to its association with Gγ. This
co-immunoprecipitated complex could have been either a PhLP1-Gβ dimer or a PhLP1-Gβ-CCT
ternary complex. Second, Gγ does not associate with CCT (68,69), indicating that Gβ must be
released from CCT prior to its association with Gγ. Third, the rate of Gβ release from CCT was
increased more than 3-fold in the presence of PhLP1 and that rate was not increased further by
addition of Gγ (69). These findings are all consistent with a release of PhLP1-Gβ from CCT
prior to its association with Gγ. This said, we have not been able to purify PhLP1-Gβ complexes,
suggesting that the complex is short-lived. It seems likely that Gγ binding occurs very quickly
after PhLP1-Gβ is released from CCT.
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Thus far, we have not addressed the fate of Gγ after its synthesis and prior to its
association with Gβ. Gγ can be expressed in cells in the absence of Gβ, although the expression
level is much less than in the presence of Gβ (69). Little is known about the fate of Gγ after its
synthesis by the ribosome. It is unlikely that Gγ folds into a stable structure in the absence of Gβ
(50), thus Gγ is a good candidate for chaperone assistance. In fact, Dupre et al. have reported an
interaction between the J-domain containing chaperone, DRiP78 and Gγ. DRiP78 bound Gγ and
protected it from degradation (76). They also saw an interaction between PhLP1 and DRiP78 and
suggested that this interaction facilitates the transfer of Gγ to Gβ bound to PhLP1. It is important
to note that Gγ binds the opposite face of Gβ as PhLP1, so their binding sites do not overlap (65).
As a result, Gγ could readily associate with Gβ while PhLP1 is still bound. Once formed, Gβγ is
a very stable dimer that can only be dissociated by denaturation (34). In the dimer, the Cterminal CaaX motif of the Gγ subunit is prenylated with either a farnesyl or a geranylyl
isoprenoid, greatly increasing the affinity of Gβγ for lipid bilayers (77).
Association of Gβγ with Gα
Association of Gβγ with Gα is believed to occur on the cytoplasmic face of the
endoplasmic reticulum membrane (77). In the process, PhLP1 must be released from Gβγ
because the PhLP1 binding site on Gβγ overlaps with both the Gα binding face and the
membrane binding surface of Gβγ (65). Furthermore, Gα has a much stronger affinity than
PhLP1 for Gβγ (78,79). This prediction was confirmed experimentally as Gαi3 was found to
displace PhLP1 from nascent Gβγ in co-expression experiments in HEK-293 cells (64).
Substantially less is known about the course of Gα prior to its association with Gβγ,
though studies suggest it may also require chaperones to facilitate its folding and/or assembly
with Gβγ. One study showed that transducin α (Gαt) co-immunoprecipitates with CCT when
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expressed in reticulocyte lysates (80), suggesting that Gα subunits may also be a CCT substrate.
Additionally, CCT-bound Gαt was more susceptible to protein degradation and was released
from CCT with the addition of ATP, both characteristics of other CCT substrates. Moreover,
reticulocyte translated Gαt could be activated by light-activated rhodopsin, indicating that the Gαt
had reached its native conformation. Comparable assays in rat retinal rod cells showed a similar
association of Gαt with CCT (80). Currently, no other evidence links CCT to the folding or
assembly of other Gα subunits, though CCT’s role in Gα folding certainly warrants further
investigation.
Another potential chaperone of Gα subunits is the non-GPCR guanine-nucleotide
exchange factor (GEF) resistance to inhibitors of cholinesterase 8 (Ric-8). Ric-8A stimulates the
exchange of GTP for GDP for Gαi, Gαq and Gα12/13, while Ric-8B acts as a GEF for Gαs (81,82).
Genetic studies in C. elegans (83) and D. melanogaster have implicated Ric-8 in G protein
regulation of centrosome movements during cell division (84-86). In C. elegans, Ric-8 is
required for cortical localization of GPA-16, a Gα homolog (87), and loss-of-function Ric-8
mutants in Drosophila resulted in defects in gastrulation, neuroblast differentiation, spindle
orientation, and asymmetric division (84-86). Upon further investigation, these Drosophila
studies showed that Gαi, Gαo, and Gβ did not localize to the plasma membrane in Ric-8 mutants,
but rather to the cytosol. Moreover, the steady state levels of Gαi and Gβ were also reduced in
Ric-8 mutants compared to wild type, and Gαi did not associate with Gβ in Ric-8 mutants (8486). Likewise, Ric-8B promotes expression of Gαolf and Gαs in mammalian cultured cells
(88,89), and Ric-8A or Ric-8B co-expression with Gα subunits in insect cells greatly increases
Gα levels (90). Recent gene-deletion studies of Ric-8A and Ric-8B show dramatic effects on the
expression of Gαi, Gαq and Gα13 or Gαs, respectively, which resulted in pleiotropic G protein
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signaling defects (91). Ric-8 gene deletion also resulted in less efficient localization of G
proteins to the plasma membrane and increased degradation (91).Studies using in vitro
translation systems strengthen the chaperone hypothesis. Gαs translated in Ric-8 deplete RRL
were more susceptible to limited trypsinization compared to mocked deplete RRL or
recombinant Ric-8-supplemented RRL, suggesting that Gα is not properly folded in the absence
of Ric-8 (92). Similar experiments from wheat germ extract, which does not contain any Ric-8
homolog, showed similar results (92). Together, all these studies suggest that Ric-8 binds to Gα
as a chaperone to stabilize the subunit and facilitates its association with βγ subunits. Once the
Gαβγ heterotrimer is formed, Gα is palmitoylated and the heterotrimer is trafficked to the plasma
membrane, most likely in a complex with a GPCR (77).
Specificity of PhLP1-mediated Gβγ assembly
Most of the work on Gβγ assembly has focused on the Gβ1γ2 dimer, a common Gβγ pair.
However, there are five Gβ isoforms and twelve Gγ isoforms. Gβ1 and Gβ4 can form dimers with
all Gγs, while Gβ2 and Gβ3 are more selective (93). In contrast, Gβ5 does not interact with Gγs in
vivo but instead forms dimers with the regulator of G protein signaling (RGS) subfamily 7,
which consists of RGS6, 7, 9 and 11 (94). These RGS proteins have a Gγ-like (Ggl) domain that
binds Gβ5 very similarly to the binding of Gγ to the other Gβs (27), and they play an important
role in turning-off G protein signals in neuronal cells (94). An important question that arose from
the Gβγ assembly work was whether PhLP1 and CCT were involved in the formation of all Gβγ
and Gβ5-RGS combinations or just a subset. A related question was whether PhLP1 and CCT
contributed to the specificity of Gβγ interactions by determining which Gβ subunits interacted
with which Gγ subunits. To address these questions, we performed a comprehensive study of the
role of PhLP1 in the assembly of the various Gβγ and Gβ5-RGS combinations. In co-
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immunoprecipitation experiments, we found that PhLP1 bound all five Gβ subunits. Binding of
Gβ1-4 to PhLP1 was similar, while binding of Gβ5 to PhLP1 was ~4-fold weaker than the other
Gβs. Furthermore, the assembly of Gβ1-4 with Gγ2 was inhibited by 70-80% by a 70% siRNAmediated PhLP1 knockdown (95). Similarly, over-expression of the dominant negative PhLP1
∆1-75 variant reduced assembly of Gβ1-4 with Gγ2 by 80-90%. These results show that PhLP1
assisted in the assembly of all four Gβs that form dimers with Gγs. In the reciprocal experiment,
dimer formation between Gβ2 and all twelve Gγ subunits was inhibited by ~80% upon PhLP1
knockdown or PhLP1 ∆1-75 over-expression (95). Another study showed that Gβ1-4 all bound
CCT and that CCT was required for Gβ1γ2, Gβ1γ3, and Gβ2γ3 assembly (68). Together, these
results indicate that PhLP1 and CCT are required for assembly of all Gβγ combinations.
Our lab also studied the effect of PhLP1 on the specificity of Gβγ dimer formation (95).
Gβ2 was used in this study because it forms dimers with some Gγs but not others. The data
reflect this observation. Gβ2 dimer formation was strong with Gγ subfamily II (Gγ2,3,4 and 8),
moderate with Gγ subfamily III (Gγ7, 12), and generally weak with subfamilies I (Gγ1, 9 and
10) and IV (Gγ5, 10) and not observed with subfamily V (Gγ13) (95). Inhibition of PhLP1
activity by siRNA knockdown or PhLP1 ∆1-75 over-expression did not change this order of
Gβ2Gγx specificity at all, but consistently inhibited dimer formation by ~80% no matter the
original extent of Gβγ dimer formation (95). This result shows that PhLP1 does not influence the
specific of Gβγ interactions, but simply facilitates association of Gβγ dimers that are intrinsically
stable. Furthermore, the fact that the stability of Gβ2γx dimers segregates so nicely into Gγ
subfamilies shows that the specificity is inherent in the complementarity of the binding surfaces
between Gβ2 and the Gγ subunits as determined by the amino acid sequences of the Gγ subunits
themselves (95).
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Assembly of the RGS-Gβ5 dimer
The structure of the RGS9-Gβ5 dimer shows that the Ggl domain of RGS9 occupies the
same position on the Gβ5 β-propeller as does Gγ1 on the Gβ1 β-propeller (Figure 1-3) (27,65).
This structural similarity suggests that Gβ5-RGS dimers may be assembled by a similar
mechanism as Gβγ dimers. However, Gβ5 binds both CCT and PhLP1 weaker than Gβ1 (68,69),
suggesting that there are significant differences between Gβ5-RGS and Gβγ assembly. To
address this issue, we assessed the contribution of PhLP1 and CCT to the formation of the Gβ5RGS7 dimer in HEK-293 cells (95). An 80% PhLP1 siRNA knockdown caused a 2-fold
reduction in the rate of Gβ5-RGS7 assembly. This decrease was less than the 5-fold decrease
seen with Gβ1γ2 assembly (64,69). In the case of CCT, a 50% siRNA knockdown caused a 2-fold
reduction in the rate of Gβ5-RGS7 assembly as well as a 2-fold decrease in Gβ1γ2 assembly (95).
From these results, it appears that Gβ5-RGS7 assembly is as dependent on CCT as is Gβγ
assembly, but it may be less dependent on PhLP1. We went on to carry out a series of additional
experiments to try to determine what might be different about the role of PhLP1 in Gβ5-RGS7
assembly. First, we looked at the effects of over-expression of PhLP1 on the rate of Gβ5-RGS7
assembly. Surprisingly, PhLP1 over-expression caused a small ~25% decrease in the rate of Gβ5RGS7 assembly. This decrease is compared to a 4-fold increase in Gβ1γ2 assembly upon PhLP1
over-expression (64,69). Second, we measured the effects of PhLP1 over-expression on the
binding of Gβ5 to CCT. There was a striking 10-fold increase in the amount of Gβ5 associated
with CCT upon PhLP1 over-expression whether RGS7 was co-expressed or not (95). This effect
is in stark contrast to the observed release of Gβ1 from CCT upon PhLP1 over-expression (69).
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These differences in the
contribution of PhLP1 to Gβ5-RGS and
Gβγ assembly may be explained by
differences in the binding of PhLP1 to
the two dimers. PhLP1 binds Gβ1γ2
with a 100 nM binding affinity and
Figure 1-3. Comparison of the structures of the
phosducin-Gβγ and RGS9-Gβ5 complexes. Phosducin binds
the same face of Gβ1 as does the N-terminal DEP/DHEX
domain of RGS9 on Gβ5. This steric hindrance blocks PhLP1
from binding to the Gβ5-RGS dimer. The color code of the
proteins is: phosducin – teal, Gβ1 – blue, Gγ1 – red, Gβ5 –
dark blue, RGS DEP/DHEX domain – pink, RGS Gγ-like
domain – dark red, RGS domain – orange. PDB numbers for
the structures are: phosducin-Gβγ (1AOR) (65) and RGS9Gβ5 (2PBI) (27).

Gβ5γ2 with a 440 nM binding affinity,
while it shows no measurable binding
to RGS9-Gβ5 (95). The structural basis
for these binding differences can be

seen by examining the crystal structures of phosducin-Gβγ and RGS9-Gβ5 complexes (Figure 13). As mentioned above, phosducin binds Gβγ on the same face as Gα, which is on the opposite
side of the β-propeller as the Gγ binding face (65). With its homology to phosducin and similar
binding contacts (54,64,66), PhLP1 would be expected to bind Gβγ like phosducin. Thus, Gγ can
associate with Gβ while PhLP1 is bound. This is not the case with RGS9-Gβ5. Its structure
shows that the N-terminal lobe (the DEP/DHEX domain) of RGS9 interacts with the same face
of Gβ as PhLP1(27). This overlap in the binding sites must preclude the formation of a PhLP1Gβ5-RGS9 complex. As a result, PhLP1 must be released from Gβ5 before an RGS protein can
bind.
A model for Gβ5-RGS assembly which is consistent with current data is presented in
Figure 1-2B. This model has important similarities and differences to the Gβγ assembly model.
In both models, Gβ1 and Gβ5 require CCT for their folding. However, PhLP1 does not promote
the release of Gβ5 from CCT as it does for Gβ1; rather it stabilizes the interaction, presumably to
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enhance folding of Gβ5. Moreover, PhLP1 must be released from Gβ5 prior to its association
with the RGS protein, whereas it may remain associated with Gβ while Gβ binds Gγ. This need
for PhLP1 in Gβ5 folding coupled with the requirement for release of PhLP1 prior to Gβ5-RGS
assembly allows for both the observed decrease in Gβ5-RGS7 assembly when the cellular level
of PhLP1 is decreased in the siRNA experiments and also the observed decrease in assembly
when PhLP1 is increased in the over-expression experiments. The model goes on to predict that
the RGS protein associates with Gβ5 while it is still bound to CCT, again in contrast to the Gβγ
assembly model in which Gβ must be released from CCT prior to association of Gγ. This
prediction is based on the observation that Gβ5 recruits RGS7 to CCT, creating an RGS7-Gβ5CCT ternary intermediate (95). The nascent RGS protein may be delivered to Gβ5 on CCT by the
Hsc70 chaperone given that Hsc70 is known to deliver folding clients to CCT (18) and an
interaction between Hsc70 and RGS7 has been reported previously (96). Once the Gβ5-RGS7
dimer is formed on CCT, it can then be released to interact with its membrane anchoring protein.
Only then is the complex fully stabilized and able to carry out its function in accelerating GTP
hydrolysis on Gα subunits (97).
Conclusion
Research over the past decade has yielded considerable insight into the mechanism of
assembly of the obligate dimers of Gβ subunits with Gγ subunits and RGS proteins. The data
point to PhLP1 as an important co-chaperone with CCT in the folding and assembly of all
complexes containing Gβ subunits. Yet there are many questions that remain. For example, all of
the work on the mechanism of dimer assembly has been done in cell culture and thus needs to be
examined in vivo. Toward this end, we have prepared conditional knockout mice of Phlp1 in
retinal rod and cone cells which are described in Chapter 2. Another question is whether PhLP1
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serves as a co-chaperone for other proteins or performs any other functions. In seeking to answer
this question, we serendipitously discovered a novel regulator of β-tubulin folding by CCT, the
programmed cell death protein 5 (PDCD5), which is discussed further in Chapter 3.
Finally and perhaps most importantly, can this information be exploited to create new
drug targets to modulate G protein signaling at the level of G protein complex assembly? Could
small molecule inhibitors or enhancers of the PhLP1-Gβ interaction be used to control the
amount of Gβγ and Gβ5-RGS dimers made by the cell? The RGS proteins themselves have been
forwarded as a good therapeutic target (98). It seems that targeting the assembly of Gβγ and Gβ5RGS dimers is also a promising avenue of translational research to explore. Such targeting
molecules could be useful pharmacological tools in the treatment of some of the many diseases
associated with malfunctions in G protein signaling.
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CHAPTER 2:
CHARACTERIZATION OF PHOSDUCIN-LIKE PROTEIN 1 GENE DELETION IN
CONE CELLS OF THE MOUSE RETINA
Summary
*

Signaling in retinal photoreceptors is mediated by canonical G protein pathways.

Previous in vitro studies have demonstrated that Gβ subunits rely on CCT and its co-chaperone
PhLP1 to fold and assemble into Gβγ and RGS-Gβ5 heterodimers. The importance of PhLP1 in
the assembly process was demonstrated in vivo in a retinal rod photoreceptor-specific deletion of
PhLP1. To test whether this mechanism applied to other cells, we prepared a second mouse line
that specifically disrupts the PhLP1 gene in cone photoreceptor cells and measured the effects on
G-protein expression and cone visual signal transduction. In PhLP1 depleted cones, Gβ3 levels
were dramatically reduced, resulting in ~70% decrease in the levels of its Gαt2 and Gγ8 binding
partners. This decreases caused an ~10-fold decrease in cone photoreceptor sensitivity in fullfield electroretinograms (ERGs) and a 60-fold decrease in transretinal ERGs. RGS9-Gβ5
complexes were also substantially reduced as shown by immunofluorescent staining and resulted
in a 50-fold increase in cone photoresponse recovery time. These results demonstrate a common
mechanism of Gβγ and RGS9-Gβ5 assembly in rods and cones and suggest that PhLP1 and CCTmediated assembly of these complexes is shared in other cells, underlining the significance of
these chaperones in G protein signaling.
Introduction
Phototransduction is the process by which light activates an electrical response in
photoreceptor cells. Vertebrates rely on two types of photoreceptors: rods and cones. Rods
*

I performed the work represented in Figures 3-3–3-6 with the help of Devon Blake, a spectacular undergraduate in
our lab. The work in Figure 7 was performed by Alexander Dr. Kolesnikov of the Kefalov lab at the Department of
Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO.
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function in low light conditions, whereas cones are specialized for brighter light conditions.
Signaling in both photoreceptors is mediated by canonical G protein signaling. The GPCR in
rods is rhodopsin. There are multiple cone opsins and the
number varies for each species. Humans have three which
correspond to long (red ~557 nm), middle (green 530 nm),
and short (blue 426 nm) wavelengths. Mice only have two:
middle with maximum sensitivity at 508 nm and short with
maximum sensitivity at 360 nm (99).
Both rods and cones have four primary structural
regions: the outer segment, inner segment, cell body and
synaptic terminus (see Figure 2-1). The outer segment is
Figure 2-1. Structure of rod and
cone photoreceptors.

composed of densely packed membrane discs that house all
the molecular components for phototransduction, including

the GPCRs, which serve as a major structural component of the discs. The inner segments
contain the ER and mitochondria and provide the high amount of energy needed for
phototransduction. The cell body contains the nucleus, and the synaptic terminus transmits the
signal from the photoreceptor to the bipolar cells.
In the absence of light, there is a constant current of inward flowing sodium and calcium
cations that maintain the photoreceptor in a depolarized state, constantly releasing the inhibitory
neurotransmitter glutamate onto the downstream bipolar cells. This steady cation conductance is
referred to as the “dark current.” Upon light stimulation, the ion channels are closed, leading to
hyperpolarization of the photoreceptor and termination of glutamate release. The decrease in
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glutamate release is detected by the downstream bipolar cells. Then the signal is amplified and
transmitted to the brain.
Most vertebrate species use the chromophore 11-cis-retinal as a ligand covalently bound
to visual GPCRs (99,100). 11-cis-retinal acts as an antagonist to the GPCR until it absorbs a
photon of light upon which it isomerizes to all-trans retinal, a powerful agonist to the receptor.
This isomerization causes a dramatic conformational change in the receptor, opening its
intracellular domain and allowing binding of the α subunit of transducin, the G protein (Gαt)
responsible for signaling in photoreceptors. The bound Gαt then exchanges its GDP for GTP and
dissociates from the receptor whereupon it binds and activates a phosphodiesterase (PDE). PDE
activation causes the intracellular cGMP concentration to decrease, which closes cGMP-gated
ion channels and results in membrane hyperpolarization and termination of glutamate release.
The mechanism of rod photoreceptor G-protein signaling is shown in Figure 2-2 (101).
Rod physiology and
phototransduction is better understood
because rods are more easily isolated than
cones. Additionally, cone studies in mouse
models are complicated by the relatively
low cone abundance in the retina, with
cones representing only 3% of the
Figure 2-2. The cycle of G protein activation and
inactivation in phototransduction. See text for details.
Reprinted from (101).

photoreceptors (99). Despite their low
abundance, advancements in gene

targeting technology have allowed researchers to more effectively study cone signaling in the
mouse (99). One study showed that knockout of a neural leucine zipper transcription factor (Nrl-
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/-) alters cell fate so that rods develop into cone-like receptors (102). A second study showed that
deletion of the Gαt gene (GNAT-/-) blocks all phototransduction through the rods without causing
photoreceptor degeneration, unlike many other knockout mice targeting rod phototransduction
components (103). Lastly, a line expressing EGFP in cones facilitates their easy
identification (104).
The photoreceptor serves as a great model for studying G-protein signaling in vivo.
Consequently, our lab sought to develop a conditional knockout mouse of PhLP1 to confirm the
proposed mechanisms of PhLP1-mediated Gβγ assembly based on our previous work in vitro
and in cell models (58,64,69,95). We engineered a conditional knock-out mouse in rod
photoreceptors using the Cre-lox selection method, driven by the rhodopsin promoter (70).
Specific deletion of PhLP1 caused a dramatic decrease in the levels of rod Gt subunits as
compared to WT animals, despite equal levels of the corresponding mRNA. These dramatic
decreases are directly attributed to the inability of Gβ and Gγ to form heterodimers, as show by
Gβγ isolation from rod outer segment purifications and whole retina extracts. The loss of Gβγ
dimers resulted in a four-fold decrease of Gαt1. Interestingly, Gβ was decreased by only 68%,
even though no Gβγ dimers were detected. Co-immunoprecipitations showed an increase of Gβ
bound to CCT in PhLP-deleted animals compared to controls. This increase suggests that, in the
absence of PhLP1, Gβ is stabilized through accumulation on CCT. This accumulation likely
caused the progressive retinal degeneration seen in the PhLP1 knockout mice. Additionally,
PhLP1 deletion severely impaired visual behavior and electrophysiological responses. Perhaps
the most novel finding was how crucial PhLP1 was in the assembly of RGS9-Gβ5 complexes.
Our previous studies with RGS7 in cultured cells suggested only partial dependence on PhLP1
for complex assembly (95), whereas in PhLP1 knockout rods both Gβ5 and RGS9 expression
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was decreased by 95%. This depletion completely matched the slow rate of photoresponse
recovery measured in both dim and saturating flashes (70).
With the findings of the PhLP1 rod knockout, the natural progression would be to
investigate the same effects in cones. PhLP1 deletion in cones would test whether the mechanism
of Gβγ and RGS9-Gβ5 assembly was shared between rods and cones. Cone transducin consists of
Gαt2 and Gβ3γ8 while rod transducin is made up of Gαt1 and Gβ1γ1. Thus, a PhLP1 deletion in
cones would show whether Gβ3γ8 requires PhLP1 for its assembly and would provide an in vivo
test of the hypothesis, formulated from studies of Gβγ assembly in cell culture (95), that PhLP1
is required for assembly of all Gβγ combinations. In addition, deletion of PhLP1 in the cones
could provide new understanding of the differences between rod and cone signaling mechanisms.
Despite their similar functions, there are two fundamental differences between rods and cones.
Cones are less sensitive to light than rods (99,105), and cones have faster photoresponse
recovery rates than rods (99,105). The rate-limiting step in rod photoresponse recovery has been
shown to be the RGS9-Gβ5-catalyzed hydrolysis of GTP by Gαt1 (106). Cones are believed to
express more RGS9-Gβ5 than rods, which could explain the faster recovery rates in cones (107).
However, this notion has not been tested experimentally. If PhLP1 deletion in cones were to
result in loss of RGS9-Gβ5 as seen in rods, then the importance of RGS9-Gβ5 in cone
photoresponse recovery could be directly assessed. For these reasons, we prepared and
characterized a mouse line with a cone-specific PhLP1-deletion.
Experimental Procedures
Development of cone phlp1 gene deletion
All experiments with mice were performed in accordance with National Institutes of
Health policy on animal use and were approved by the Brigham Young University and
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Washington University Institutional Animal Care and Use Committees. Generation of the Phlp1loxP mouse was described previously (70). Mice containing the Phlp1-loxP were bred with the
human red/green pigment (HRGP) gene promoter (108) to achieve conditional knockout of the
Phlp1 gene in cone photoreceptors. PCR detection of the cre and Phlp-loxP genes were carried
out using the appropriate primers (HRGP: 5'-AGG TGT AGA GAA GGC ACT TAG C-3' and
5'-CTA ATC GCC ATC TTC CAG CAG G-3'; PhLP-loxp 5' GAT CAC TTT GAC TGG GGA
ATG ATT TTA GGT 3' and 5' GAG GTG GTA AGC AGG TGT ACT GGC TGG TTT 3').
Antibodies
The following antibodies used in this study. Primary antibodies: PhLP1 (109), Gαt1 and
Gγ1 (Santa Cruz), Gαt2 and Gγ8 (110), Gβ1 (111), Gβ3 (Sigma), Gβ5 (Proteintech), cone opsin
(Millipore), cone arrestin (112), RGS9-1 (113). Secondary antibodies: FITC-conjugated donkey
anti-rabbit (Jackson ImmunoResearch Laboratories), TRITC-conjugated peanut agglutinin
(Vector Laboratories), AF555-conjugate goat anti-rabbit (Life Technologies).
Immunohistochemistry and assessment of photoreceptor degeneration
The expression levels of PhLP1 and other visual signaling proteins in cone
photoreceptors were tested by immunocytochemistry as described previously (70). Briefly,
superior hemisphere of eyes from 30-40 day-old PhLP1F/FCre+ and control mice were cauterymarked for orientation. These eyes were enucleated under ambient illumination without
adaptation and were immersion-fixed for 1-2 hr. using freshly prepared 4% paraformaldehyde in
0.1 M phosphate buffer (pH 7.4) and cryo-protected overnight in 30% sucrose in 0.1 M
phosphate buffer (pH 7.4). The cornea and lens were then removed, and the eyecups were
embedded in optimal cutting temperature (OCT) compound and cryo-sectioning was performed.
Cryo-sections of 12 μm were cut through the optic nerve head along the vertical meridian and
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were placed on superfrost microscope slides. For immunohistochemistry, sections were rinsed in
0.1 M phosphate buffer, and blocked for 1 h using either 10% donkey serum or 10% normal goat
serum, 0.1% Triton X-100 in 0.1 M phosphate buffer (pH 7.4). Primary antibodies to PhLP1
(1:100 dilution), Gαt2, Gβ3 (1:200), Gγ8 (1:50,) cone opsin (1:50), RGS9-1 (1:100), or Gβ5
(1:50), were applied to each group of four sections in a humidified chamber overnight at 4°C.
After rinsing in three 10-min phosphate buffer washes, fluorescein isothiocyanate-conjugated
secondary antibodies at a 1:200 dilution, AF555-conjugated secondary antibodies at a 1:1000
dilution or TRITC-conjugated peanut agglutinin at a 1:200 dilution were applied for 1-2 h at
room temperature in a light protected, humidified chamber. The sections were viewed using an
Olympus FluoView FV1000 confocal laser scanning microscope with a 60x, 1.4 numerical
aperture oil objective lens and an optical slit setting of < 0.9 μm. Images were taken consistently
inferior to the optic nerve of each section.
To aid in proper immunolocalization of signaling proteins that are expressed in both rods
and cones (PhLP1, RGS9-1, Gβ5) immunohistochemistry experiments were performed on HRGP
mice bred with enhanced green fluorescent protein (EGFP) cone-expressing mice (104). The
Phlp-loxP allele was then bred in to create a knockout that expressed EGFP in the cones.
Cryo-sections with intact morphology were used for further analysis to determine
photoreceptor degeneration by staining with TRITC-conjugated PNA to determine relative cone
size and number at mice of 1 to 9 months.
Determination of retinal protein expression
Whole retina extracts were prepared from eyes of 30-40 day-old PhLP1F/FCre+ mice and
controls under ambient illumination. These retinas were harvested and placed in ice-cold RIPA
buffer (phosphate buffered saline with 1% NP-40 and 6 μl/mL Sigma Protease inhibitor
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cocktail). The retinas were then passed through an 18G needle 20 times and a 25G needle 10
times to release the proteins. Extracts were centrifuged at 13,800 rpm for 10 min at 4°C to
remove cellular debris. Protein concentrations were determined by BCA protein assay, and
extracts with equal amounts of protein were loaded and resolved on 10% or 14% Tris-glycineSDS gels or 16.5% Tricine-SDS gels and transferred onto nitrocellulose membranes using an
iBlot transfer apparatus (Invitrogen). After blocking with LICOR Blocking buffer for 1 h,
membranes were immunoblotted for each of visual proteins as indicated. The amounts of each
protein in the immunoblots were quantified using a LICOR Odyssey near-infrared imaging
system and compared to controls.
Quantitative RT-PCR
Total RNA from whole retinas was isolated using RNeasy Mini Kit (Qiagen) according
to the manufacturer’s protocol. Approximately 2 μg of the isolated RNA was then treated with
DNase (Promega) and reverse transcribed using dT oligo primers (Invitrogen) and SuperScript
III reverse transcriptase (Invitrogen) according to the manufacturer’s instructions to synthesize
cDNA. The RT-PCR was performed using the Taq-Man gene expression assay primers and
probe mix (Applied Biosystems). Mouse Actb (Mm00607939_s1), PDCL (Mm01327170_m1),
GNAT2 (Mm00492394_m1), GNB3 (Mm00516381_m1), GNG8 (Mm00515877_g1) mRNAs
were measured on an Applied Biosystems 7500 Real-Time PCR System. The PCR was
performed under the following conditions: one cycle at 50°C for 2 min, one cycle at 95°C for 10
min, and 40 cycles at 95°C for 15 s and at 60°C for 1 min. The data were normalized to the Actb
reference. The RT-PCR results were analyzed using the ∆∆Ct method to compare the mRNA
levels of PhLP1F/FCre+ mice to controls. At least three animals of each genotype were used, and
the RT-PCR analysis was repeated three times for each animal.
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Assessment of the photo-response by Electroretinography
Electroretinograms (ERG) were measured under photopic conditions, high light
intensities that activate cones and inactivate rods, as follows. One-month old mice were first
anesthetized with isofluorane and their pupils were dilated by adding a drop of 1% tropicamide
for 15 min to the eyes. A recording electrode was placed on the cornea with a reference electrode
inserted subdermally in the cheek and a ground electrode subdermally at the base of the tail.
ERG responses were measured using an Ocuscience HMsERG system. Mice were first light
adapted for 10 min. at light intensity of 30 cd·s m˗2. Full-field photopic ERG recordings of both
PhLP1F/FCre+ and PhLP1+/+Cre+ mice were performed with flashes of increasing white light
intensities from 2.3 ×10-2 to 1.0 ×102 cd·s m˗2 followed by a recovery phase at 30 cd·s m˗2. The
recovery time between each flash varied from 10 s to 2 min depending on the flash intensities.
The amplitudes of the photopic b-wave at different light intensities were then compared between
the PhLP1F/FCre+ and PhLP1+/+Cre+ mice. The intensity–response data were fitted to the Naka–
Ruston hyperbolic function with the Hill coefficient set to 1.
Electroretinograms were also measured under scotopic conditions, low light intensities
that only activate rods, as follows. One-month old mice were dark adapted overnight and then
treated as above without any light adaptation. Full-field scotopic ERG recordings of both
PhLP1F/FCre+ and PhLP1+/+Cre+ mice were performed with flashes of increasing white light
intensities from 2.0 ×10-3 to 1.0 ×102 cd·s m-2. The recovery time of the scotopic ERG between
each flash varied from 10 s to 4 min. depending on the flash intensities. The amplitudes of the awave and b-wave at different light intensities were then compared between the PhLP1F/FCre+
and PhLP1+/+Cre+ mice. The intensity–response data were fitted to a double hyperbolic function
(114), again with Hill coefficients set to 1.
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Optomotor responses
PhLP1F/FCre+ mice were bred with GNAT-/- mice to create a double knock-out
PhLP1F/FCre+GNAT-/- to remove rod signaling that could interfere with optomotor response
tests. Visual acuity and contrast sensitivity of PhLP1F/FCre+GNAT-/- and PhLP1+/+Cre+GNAT-/mice were measured using a two-alternative forced-choice protocol (115). The Optomotry
system (Cerebral Mechanics) consisted of a square array of four computer monitors with a
pedestal in the center where the mouse was placed. An infrared-sensitive television camera and a
round array of six infrared LEDs mounted above the animal were used to observe the mouse but
not the monitors. Using a staircase paradigm, rotating stimuli (sine-wave vertical gratings) were
applied on the monitors where they formed a virtual cylinder around the mouse (116) . The
mouse responded to the stimuli by reflexively rotating its head in the corresponding direction.
Optomotor responses were measured under two background illumination conditions: scotopic
(−4.45 log cd m-2) or photopic (1.85 log cd m-2). For scotopic conditions, the background
monitor luminance was controlled by neutral density film filters.
Visual acuity was defined as the threshold for spatial frequency (Fs) of gratings with
100% contrast and measured at the speed (Sp) of 12°/s for both illumination conditions. In this
mode, Fs was gradually increased by the computer protocol until its threshold was determined.
Temporal frequency (Ft) was automatically adjusted by the computer program, based on the
following equation: Ft = Sp · Fs (115). Contrast sensitivity was defined as the inverse of contrast
threshold for optomotor responses. In this mode, contrast of the stimuli was gradually decreased
by the computer protocol until its threshold was determined. Fs was fixed at 0.128 cycles/degree,
Ft was set to 1.5 Hz, and Sp was set to 12°/s for both illumination conditions. Data were
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analyzed using independent two-tailed Student's t test, with an accepted significance level of p <
0.05.
Transretinal ERG Recordings
Transretinal ERG recordings were performed as described previously (117). Briefly,
four-week-old PhLP1F/FCre+GNAT-/- and PhLP1+/+Cre+GNAT-/- mice were dark-adapted
overnight and then whole retinae were removed from dissected eye cups and prepared for
transretinal recordings. Cone-driven test flash responses were recorded at intensities from
2.5×103 to 6.0×107 photons (μm2). The transretinal recordings were done using synaptic
inhibitors to block post-photoreceptor components of the photoresponse. The intensity–response
data were fitted to the Naka–Ruston hyperbolic function.
Results
Confirmation of the cone-PhLP1 deletion
To assess the role of PhLP1 in the assembly of Gβ3γ8 and RGS9-Gβ5 in cone
photoreceptors, we created a cone-specific knockout of PhLP1 by crossing the PhLP1-loxP
(PhlpF) mouse (70) with the HRGP mouse in which cone expression of Cre recombinase is
driven by the human cone red-green opsin promoter (108,118). Cre-mediated recombination
causes the loss of the translation initiation site of PhLP1, thus removing PhLP1 from cones as
soon as the opsins are expressed. Full disruption of the Phlp1 gene was achieved by generating
mice that were homozygous for the PhlpF allele and heterozygous for HRGP-cre allele. The
presence of the PhlpF gene was confirmed (Figure 2-3A) by a shift in the PCR product (704 bp)
compared to the wild type allele (600 bp). PhLP1 protein expression was then tested by
immunohistochemistry of PhLP1 in retinal cross-sections. However, it was difficult to
distinguish PhLP1 expression in cones from that in rods in the photoreceptor layer. To overcome
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this problem, we crossed our PhLP1F/FCre+ mouse line with a mouse line expressing enhanced
green fluorescent protein (EGFP) specifically in cones to create a PhLP1F/FCre+EGFP+ mouse
line with an EFGP marker in the cones (104). Immunolocalization of PhLP1 in these mice
showed strong PhLP1 staining in the outer segment of cones with the wild type Phlp allele
(PhLP1+/+Cre+ EGFP+) with noticeably weaker staining in rods. In contrast, PhLP1 staining was
essentially absent in cones from the knockout mice while rod staining was unchanged (Figure 23B). This result shows that PhLP1 protein expression was specifically lost in the cones of
PhLP1F/FCre+EFGF+ animals.

Figure 2-3. Characterization of the cone
photoreceptor-specific PhLP1 knock-out
mouse. A) PCR genotyping results using
the PhLP-loxP primers. The PhLP1F gene
generated a 704 bp product, while the wildtype generated a 600 bp product. B)
Immunolocalization of PhLP1 (red) in
retinal cross-sections from PhLP+/+Cre+
and PhLPF/FCre+ mice expressing EGFP
(green) in cone. An example is indicated by
a white arrow. C) Immunoblot detection of
PhLP1 from whole-retinal lysates from
PhLP+/+Cre+ and PhLPF/FCre+ mice. D)
Immunolocalization of TRITC-labeled
PNA (red) in retinal cross-sections from 1month and 9-month-old PhLP+/+Cre+ and
PhLPF/FCre+ mice.
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The greater immuno-staining of PhLP1 in cones than in rods was unexpected because it
had not been observed previously (70,109). The difference can be attributed to
immunolocalization conditions that have been optimized to specifically detect PhLP1 (see
Experimental Procedures). The enhanced PhLP1 detection suggests that PhLP1 expression is
much higher in cones than in rods. To further investigate this notion, PhLP1 immunoblots of
whole retinal lysates from PhLP1F/FCre+ and PhLP1+/+Cre+ mice (Figure 2-3C) were compared.
There was a 40% decrease in PhLP1 in the knockout, despite the fact that cones only represent
~3% of all photoreceptors suggesting that PhLP1 expression is ~10-fold higher in cones than in
rods.
Assessment of cone viability
In rod cells, loss of PhLP1 resulted in measurable degeneration of the photoreceptor layer
after one month and nearly complete loss by 6 months (70). This degeneration was evident by
shortening of the photoreceptor layer and loss of nuclei. To determine if a similar effect would
be seen in cone cells, we stained cones of one month and nine month old mice with a TRITC
conjugated peanut agglutinin, which stains the exterior of cone inner and outer segments (119).
PhLP1F/FCre+ and PhLP1+/+Cre+ mice showed similar number and size of cone cells in both one
and nine month old animals (Figure 2-3D) indicating that PhLP1 deletion does not cause cone
degeneration.
PhLP1 deletion causes a decrease in cone Gt
Although their overall mechanism for G protein signaling is the same, rods and cones
have a different Gt heterotrimers. Rod photoreceptors use Gαt1, Gβ1 and Gγ1, whereas cones use
Gαt2, Gβ3 and Gγ8. Thus the deletion of PhLP1 in cones allowed an evaluation of the
contribution of PhLP1 to Gβ3Gγ8 assembly in vivo. We first measured the expression of the cone
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Gt subunits in PhLP1F/FCre+ and PhLP1+/+Cre+ mice by immunohistochemistry. The
PhLP1F/FCre+ mice showed a marked decrease in immunolabeling of Gαt2, Gβ3 and Gγ8 in the
cones (Figure 2-4A), indicating that expression of the cone Gt subunits was substantially
reduced. In addition, the residual Gαt2 was mis-localized in the absence of PhLP1, with more
staining in the cell body and less staining in the outer segment. The effect appeared specific for
the cone Gt subunits because there was no difference in cone opsin expression or localization.
To further assess the effects of PhLP1 deletion on cone Gt expression, whole retina
extracts were immunoblotted for cone Gt subunits, other cone proteins and rod Gt subunits. Gαt2
and Gγ8 were both reduced significantly in the PhLP1 knockout, while Gβ3 was not (Figure 2-5A

Figure 2-4. Immunolocalization of G-protein subunits
in PhLP-deleted cones. A) Retinal cross-sections from
PhLP+/+Cre+ and PhLPF/FCre+ mice were probed with
antibodies specific to Gαt2, Gβ3, Gγ8, and cone opsin and
detected with FITC-conjugated secondary antibodies. B)
Retinal cross-sections from PhLP+/+Cre+ and PhLPF/FCre+
mice expressing EGFP in cones were probed with
antibodies specific to RGS9-1 and Gβ5 and detected with
AF555-conjugated secondary antibodies. Orange regions
of overlapping fluorescence indicate expression of the
probed proteins in cones. Examples are indicated by white
arrows.
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and B). The lack of change in Gβ3 expression in whole retina was not surprising since the PhLP1
deletion was limited to cone cells and Gβ3 is also expressed in other retinal cells (120,121). The
expression of other cone proteins, opsin and arrestin, was unchanged in the absence of PhLP1
(Figure 2-5B), indicating that the loss of PhLP1 specifically affected cone Gt subunit expression
and not cone protein expression in general. Rod Gt subunit expression was also unchanged,
demonstrating that the effect was limited to cones.
To determine if the reduction in cone Gt subunit expression were caused by
transcriptional or post-transcriptional events, we measured the effects of PhLP1 depletion on the
cone Gt subunit mRNA levels in whole retinal extracts. No differences in Gαt2, Gβ3 or Gγ8
mRNA levels were observed (Figure 2-5C), indicating that the reduced expression was caused by
post-transcriptional events.
PhLP1 deletion causes a decrease in cone RGS9-Gβ5
We previously observed that PhLP1 deletion in rods caused a striking >95% decrease in
RGS9-Gβ5 expression in those cells, most likely because of an inability to form RGS9-Gβ5
dimers (70). The cone-specific PhLP1 deletion provided an opportunity to test whether this strict
PhLP1-dependence for RGS9-Gβ5 assembly seen in rods was also the case in cones. To address
this question, we measured the effect of PhLP1 deletion on Gβ5 and RGS9 expression in cones
by immunohistochemistry. We again used EGFP expressing cones to distinguish between cone
and rod expression because the extensive Gβ5 and RGS9 expression in rods can mask changes in
their expression in cones. In the PhLP1+/+Cre+EGFP+ wild-type mice, expression of RGS9 was
clearly observed in cone outer segments as evidenced by the orange color produced by
overlapping fluorescence signals from EGFP (green) and RGS9 (red) in the merged image
(Figure 2-4B). In contrast, the PhLP1-/-Cre+EGFP+ knockout mice showed no orange cone outer
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segments in the merged image, indicating that RGS9 expression was substantially decreased in
PhLP1-depleted cones.
We applied the same strategy to assess Gβ5 expression in cones and observed a similar
result (Figure 2-4B). The number of orange cone outer segments indicating expression of Gβ5 in
cones was much less in the PhLP1-deleted cones than in the wild-type cones (Figure 2-4B). This
decrease in both RGS9 and Gβ5 expression in PhLP1-deleted cones argues that RGS9-Gβ5 dimer

Figure 2-5. Protein Expression in PhLP-deleted cones. A) Immunoblots of whole-retinal extracts for PhLP1,
Gt2 subunits, RGS9-1, Gβ5, opsin, cone arrestin, and Gt1 subunits. B) Quantification of the immunoblot bands in
A relative to the wild-type. C) Levels of indicated mRNAs in whole-retinal extracts were determined by RTPCR.
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formation is as dependent on PhLP1 in cones as it is in rods. We attempted to confirm the
decreased expression by immunoblotting whole retinal extract for Gβ5 and RGS9, but saw no
differences (Figure 2-5B) most likely because the high level of Gβ5 and RGS9 expression in rods
negates the ability to detect changes in cones.
PhLP1 knockout results in decreased photopic phototransduction
The loss of cone G protein and RGS protein expression should have a profound effect on
phototransduction in cones. To test this possibility, we performed a full-field ERG analysis on
PhLP1F/FCre+ and PhLP1+/+Cre+ mice. Photopic ERG responses, which rely on cone vision in
bright light, were desensitized in PhLP1F/FCre+ mice compared to control mice, as evidenced by
the decreased amplitude of the b-wave to a series of increasing light flashes (Figure 2-6A). The
stimulus-response curve showed a nearly 10-fold decrease in sensitivity, as evidenced by the
increased light-intensity required to produce a half-maximal response (I1/2) in the PhLP1-deleted
animals, (Figure 2-6C and Table 2-1). Despite the decrease in light sensitivity, there was no
significant change in the maximal response amplitude (Rmax) at high light intensity (Figure 2-6C
and Table 2-1). In contrast, scotopic ERG responses, which stem from rod vision under darkadapted conditions, were essentially the same in the PhLP1F/FCre+ and PhLP1+/+Cre+ mice
(Figure 2-6B). The sensitivity and amplitude of both the scotopic a-wave and b-wave were not
significantly different in the knockout mice (Figures 2-6D and E), indicating that rod
phototransduction was unaffected by the cone PhLP1-deletion. These ERG results demonstrate
that cone vision is severely impaired in cone-specific PhLP1 knockout mice, as would be
expected from the loss cone Gt and RGS9-Gβ5 complexes.
To clearly isolate cone photoresponse from those of rods, we bred the PhLP1F/FCre+ line
onto a Gαt1 knockout background (GNAT-/-), which removes the Gαt1 subunit from rod cells and
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Figure 2-6. ERG analysis of cone-specific PhLP1-depleted mice. A-B) Families of ERG responses for
PhLP1+/+Cre+ and PhLP1F/FCre+ mice for photopic (A) and scotopic (B) tests. Light intensity values are in log
candela seconds per square meter. C) Intensity-response relationships for photopic b waves. Data were fit to the
Naka-Ruston function that yielded the parameters in Table 2-1.D-E) Intensity-response relationships for
scotopic a waves (D) and scotopic b waves (E). Data were fit to a double hyperbolic function (114).

thus eliminates rod signaling (103). These mice were first tested for visual acuity and contrast
sensitivity by optomotor responses to rotating grid stimuli (70). We found that
PhLP1F/FCre+GNAT-/- mice showed a 35% reduction in visual acuity compared to
PhLP1+/+Cre+GNAT-/- animals (Figure 2-7A). Contrast sensitivity of PhLP1F/FCre+GNAT-/37

animals showed greater impairment with a nearly 14-fold reduction compared to wild-type
(Figure 2-7B). These results further demonstrate that cone vision is significantly diminished in
PhLP1-deleted cones.
To investigate the effects of PhLP1

Table 2-1. ERG intensity Parameters for Photopic
b-waves.
I1/2 (cd·s·m-2) Rmax (μV)
PhLP1+/+Cre+ (n=8) 4.58 ± 0.39 180 ± 3
PhLP1F/FCre+ (n=8) 39.05 ± 11.42 168 ± 19

deletion on cone signaling more specifically,
we measured photoresponses by transretinal

recordings of dark-adapted mice retinas with the GNAT-/- background at increasing light
intensities. Recordings were done using synaptic inhibitors to block post-photoreceptor
components of the photoresponse. Similar to full-field ERG readings, transretinal recordings
from PhLP1F/FCre+GNAT-/- mice showed substantial desensitization compared to wild-type
controls (Figure 2-7 C, D). The decreased sensitivity could be easily seen by comparing the
responses at 5.7×104 photons µm-2 (Figure 2-7C & D: red lines). Stimulus-response curves
further illustrated the decreased sensitivity, showing a 58-fold increase in I1/2 in the knockout
mice with no change in Rmax (Figure 2-7E and Table 2-2). This desensitization is nearly six times
larger than that seen in the full-field ERG recordings, suggesting that rod photoresponses were
not completely abrogated in the full-field ERG tests. Both the photopic ERGs and the transretinal
recordings showed no difference in the maximum cone response amplitudes between
PhLP1+/+Cre+ and PhLP1F/FCre+ mice (Figure 2-7E), indicating that the number and length of
the cones were the same in the two mouse lines as observed in the cone morphology data (Figure
2-3D). From the trans-retinal data, we were able to assess the effect of PhLP1 deletion on the
cone photoresponse amplification rate by comparing the intensities of light require to produce
identical response activation phases. We compared population-averaged fractional responses in
the linear range that corresponded to 5.7×104 photons µm-2 for PhLP1F/FCre+GNAT-/- retina, and
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Figure 2-7. Visual behavioral and transretinal ERG
responses of PhLP1-deleted mice. A) Photopic visual acuity.
B) Photopic contrast sensitivity. All data are means ± SEM. CD) Representative families of transretinal ERG flash responses
from PhLP+/+Cre+GNAT-/- (C) and PhLP1F/FCre+GNAT-/- (D)
mice are shown. Test flashes of increasing intensities were
delivered at time 0. The red traces show responses to an
intensity of 5.7×104 photons µm-2. E) Intensity response
functions for transretinal ERG responses from
PhLP+/+Cre+GNAT-/- (n=9) and PhLP1F/FCre+GNAT-/- (n=13)
mice. Data were fit to the Naka-Ruston function that yielded
the parameters in Table 2-2. F) Amplification of the
phototransduction cascade in mouse cones. The inset shows the rising phase of the responses on an extended
time scale. See text for details. G) Kinetics of the dim flash responses. Normalized population-averaged dim
flash responses to light intensities of 2.4×103 photons µm-2 for PhLP1+/+Cre+GNAT-/- (n=9) and 5.7×104
photons µm-2 for PhLP1F/FCre+GNAT-/- (n =12), demonstrating the decelerated photoresponse recovery in
PhLP1-deleted cones. The inset shows an extended time scale.
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Table 2-2. Transretinal ERG parameters.
I1/2 (photons um-2)
Rmax (μV)
+/+
+
1.5×104 ± 1.1×103 51.9 ± 0.95
PhLP1 Cre (n=9)
PhLP1F/FCre+ (n=13) 8.6×105 ± 3.5×105 52.0 ± 5.92

τrec (ms)
22
1110

Tpeak (ms)
56
226

2.4×103 photons µm-2 for PhLP1+/+Cre+GNAT-/- retina. To obtain the best match of the rising
phase, the fractional dim flash PhLP1F/FCre+GNAT-/- response required downscaling by a factor
of 4.5. The ratio of the two light intensities corrected by the scaling factor yielded a 5.2-fold
reduction in the signal amplification rate in PhLP1F/FCre+GNAT-/- retina. This reduction
corresponds well to the nearly 3.5-fold reduction seen in Gαt2 levels observed in
PhLP1F/FCre+GNAT-/- cones.
PhLP1 knockout results in prolonged photo response recovery
RGS9-Gβ5 is highly expressed in cones and is believed to contribute substantially to the
rapid photoresponse recovery rate characteristic of cones (107,122,123). Thus, the loss of RGS9Gβ5 upon PhLP1 deletion (Figure 2-4B) would be expected to decrease the recovery rate. In fact,
there was a striking delay in the recovery phase of the cone photoresponse (Figure 2-7G). The
dim flash recovery time constant (τrec) was increased 50-fold (Table 2-2), ten times more than
was seen upon PhLP1 deletion in rods (70). This dramatic decrease in the cone recovery rate is
very similar to that observed in RGS9 knockout mice (123) and provides addition evidence that
RGS9-Gβ5 plays a key role in the rapid kinetics of cone photoresponses.
Discussion
PhLP1 and cone Gt function
Specific deletion of PhLP1 in cone photoreceptors demonstrates its essential role in cone
physiology. The loss of PhLP1 substantially reduced expression of the subunits of the cone Gt
heterotrimer (Figures 2-4 and 2-5), and resulted in a marked attenuation of photopic
photoresponses (Figures 2-6 and 2-7). These findings mirror those of the rod-specific PhLP1
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deletion, which showed similar reductions in rod Gt subunits, resulting from an inability to form
Gβ1γ1 heterodimers (70). Likewise, the observed loss of cone Gt can be attributed to an inability
to form Gβ3γ8 dimers in the absence of PhLP1. This observation provides in vivo evidence for
the hypothesis, developed from studies in cell culture, that all Gβγ dimer combinations require
PhLP1 for their assembly (95). The loss of Gβ3γ8 leads to a reduction in Gαt2 and its mislocalization from the cone outer segment to the inner segment and cell body (Figure 2-4A).
Interestingly, a recent study of a Gβ3 knockout mouse showed a similar mis-localization of Gαt2
in the outer segment (124), lending further support to the idea that Gβ3γ8 plays an important role
in the localization of Gαt2 to the outer segment.
The reduction in cone Gt subunits was accompanied by a substantial decrease in photopic
vision, demonstrated by full-field ERG and visual behavioral tests (Figure 2-6 and 2-7A, B).
This effect was even greater in trans-retinal ERG tests, with a 58-fold decrease in cone light
sensitivity and a 5.2-fold decrease in the amplification constant, when all rod signaling was
removed by Gαt1 deletion (Figure 2-7, Table 2-2). However, the maximum amplitude of the
cone photoresponse was unchanged, indicating that other components of the cone visual cascade
such as cone opsin, phosphodiesterase and the cGMP-gated cation channel remained intact in the
PhLP1 knockout. These effects on cone phototransduction are similar to those of the Gβ3
knockout (124), supporting the idea that formation of functional Gβ3γ8 dimers was greatly
reduced in the absence of PhLP1.
The residual cone photoresponse in the absence of PhLP1 or Gβ3 raises questions about
the role of Gβ3γ8 in Gαt2 activation by cone opsin. In both the Gβ3 knockout and the cone PhLP1
knockout, the decrease in the amplification constant was roughly proportional to the decrease in
Gαt2 levels in the cone outer segment. This observation suggests that Gβ3γ8 does little to improve
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the efficiency of Gαt2 coupling to cone opsin. Considerable insight into G protein activation has
come from the atomic structure of the complex between Gs and the agonist-bound β-adrenergic
receptor (24). In this complex, there were no direct contacts between Gβ1γ2 and the receptor, but
interactions between Gβ1 and the N-terminus of Gαs positioned the N-terminus next to the
membrane where it made important contacts with the receptor. In the case of Gt2 and cone opsin,
these interactions may be less important for activation. It should be noted that residual signaling
probably does not result from compensation by another Gβγ pair in Gαt2 activation because in
the PhLP1 knockout all Gβγ assembly should be equally disrupted in the absence of PhLP1 (95).
Collectively, these observations suggest that the most important role of Gβ3γ8 in cone signaling
is not to improve receptor coupling, but to stabilize Gαt2 and increase its interaction with the
cone outer segment membrane.
PhLP1 and RGS9-Gβ5 assembly in cones
The loss of Gβ5 and RGS9 in the cone PhLP1 knockout (Figure 2-4B) is indicative of an
inability to form RGS9-Gβ5 dimers. Previous work has shown that deletion of either Gβ5 or
RGS9 results in complete loss of the other (113,125). This profound loss of both Gβ5 and RGS9
in the absence of PhLP1 was also observed in rods (70), thus both rods and cones exhibit a strict
requirement for PhLP1 in RGS9-Gβ5 assembly. Several studies have shown that cones express
higher levels of RGS9-1 and Gβ5 than rods, which is believed to contribute to the rapid
deactivation kinetics of cones (107,122). Perhaps this is why PhLP1 expression was found to be
higher in cones than in rods (Figures 2-3 and 2-5).
The loss of RGS9-Gβ5 complexes resulted in a 50-fold increase in recovery time (Figure
2-7, Table 2-2). These results parallel those measured in cones of RGS9-/- mice, which showed a
60-fold increase in recovery time (123). This nearly identical increase suggests that RGS9-Gβ5
42

complexes are virtually non-existent in PhLP-deleted cones, advocating a strict dependence of
RGS9-Gβ5 complex formation on PhLP-mediated assembly.
PhLP1 and cone viability
PhLP1 deletion in rods resulted in photoreceptor degeneration, yet we did not observe a
similar degeneration in cones (Figure 2-3D). The proposed cause of rod degeneration was the
accumulation of Gβ1 on CCT (70). The lack of degeneration in cones would suggest that the
chaperonin system is not as compromised by the loss of PhLP1. One possibility is that Gβ3 is
more easily cleared from CCT than Gβ1. Consistent with this hypothesis, Gβ3 has been shown to
have lower affinity for CCT than Gβs 1, 2, and 4 (68). Alternatively, rod-derived survival factors
may maintain cone viability (126,127) despite possible insults to the cone proteome from
diminished CCT function in the absence of PhLP1.
In summary, the deletion of PhLP1 in cone photoreceptors results in the loss of cone Gt
heterotrimers and RGS9-Gβ5 dimers and leads to a marked reduction in cone light sensitivity and
a greatly retarded photoresponse recovery. These findings mimic those of the PhLP1 deletion in
rod photoreceptors (70), demonstrating a common mechanism of Gβγ and RGS9-Gβ5 in rods and
cones. These results predict that PhLP1 and CCT-mediated assembly of these complexes is
shared in other neurons, highlighting the importance of these chaperones in G protein signaling.
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CHAPTER 3:
PROGRAMMED CELL DEATH PROTEIN 5 INTERACTS WITH THE CYTOSOLIC
CHAPERONIN CCT TO REGULATE β-TUBULIN FOLDING
Summary
*†

Programmed cell death protein 5 (PDCD5) has been proposed to act as a pro-apoptotic

factor and tumor suppressor. However, the mechanisms underlying its apoptotic function are
largely unknown. A proteomics search for binding partners of phosducin-like protein, a cochaperone for the chaperonin CCT, revealed a robust interaction between PDCD5 and CCT.
PDCD5 forms a complex with CCT and β-tubulin, a key CCT folding substrate, and specifically
inhibited β-tubulin folding. Cryo-electron microscopy studies of the PDCD5-CCT complex
suggested a possible mechanism of inhibition of β-tubulin folding. PDCD5 bound the apical
domain of the CCTβ subunit, projecting above the folding cavity without entering it. Like
PDCD5, β-tubulin also interacts with the CCTβ apical domain, but a second site is found at the
sensor loop deep within the folding cavity. These orientations of PDCD5 and β-tubulin suggest
that PDCD5 sterically interferes with β-tubulin binding to the CCTβ apical domain and inhibits
β-tubulin folding. Given the importance of tubulins in cell division and proliferation, PDCD5
might exert its apoptotic function at least in part through inhibition of β-tubulin folding.
Introduction
In seeking to determine if PhLP1 were involved in the folding of other CCT substrates,
particularly other β-propeller proteins, we identified a novel interaction of CCT with
*
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Shaw, and Rebecca Plimpton of BYU and Jorge Cuellar of the Valpuesta Lab at the Centro Nacional de
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programmed cell death protein 5 (PDCD5). PDCD5 was originally described as an up-regulated
gene from cells undergoing apoptosis (129). Cellular expression of PDCD5 is decreased in many
cancer cell lines and tumors (130,131). Moreover, over-expression of PDCD5 accelerates
apoptosis in tumor cells (132), suggesting that PDCD5 plays a role in stemming uncontrolled cell
proliferation by triggering apoptosis. It has been proposed that apoptotic stimuli cause
translocation of PDCD5 to the nucleus, where it interacts with the histone acetyltransferase
Tip60 and the transcription factor p53 to promote programmed cell death (133,134).
In contrast to these observations, our data show that PDCD5 interacts with CCT in the
cytosol as a regulatory co-chaperone that specifically inhibits β-tubulin folding. Based on these
findings, we propose that the apoptotic activity of PDCD5 may result at least in part by
impairing CCT-mediated β-tubulin folding.
Experimental Procedures
Cell culture
HEK-293T and U2OS cells were cultured in 1:1 DMEM/F-12 growth media containing
2.5 mM L-glutamine and 15 mM HEPES supplemented with 10% fetal bovine serum. The cells
were sub-cultured regularly to maintain growth but were not used beyond 20 passages.
Preparation of cDNA constructs
Human PDCD5 (N-terminal FLAG tagged, N-terminal FLAG-TEV tagged, or C-terminal
FLAG tagged) and tubulin-binding protein co-factors A (TBCA) and B (TBCB) with C-terminal
FLAG tags (Open Biosystems) were cloned in the pcDNA3.1/myc-His B vector (Invitrogen)
using PCR. C-terminally c-myc-tagged human PhLP1 in pcDNA3.1/myc-His B vector was
described previously (64). For recombinant protein purification, His6-PDCD5-FLAG was cloned
into the first multiple cloning site of the bacterial expression vector pETDuet, and PhLP1-myc-

45

His was cloned into the bacterial expression vector pET15b (Novagen) using PCR. The integrity
of all constructs was confirmed by sequence analysis. The N-terminally hemagglutinin (HA)tagged Gγ2 and FLAG epitope-tagged Gβ1 cDNAs also in the pcDNA3.1 vector were obtained
from the UMR cDNA Resource Center. BzF tRNA and synthetase cDNAs were a generous gift
from Thomas Sakmar (Rockefeller University).
Transient transfections
HEK-293T and U2OS cells were grown in 6-well plates, 60-mm dishes, or 100-mm
dishes to 80-90% confluency at which point they were transfected with 1 μg (6-well plate), 2-5
μg (60-mm dishes), or 6 μg (100-mm dishes) each of the indicated vectors using Lipofectamine
2000 according to the manufacturer’s protocol (Invitrogen). After 48 hours, the cells were
harvested for immunoprecipitation, mass spectrometry, or radiolabel pulse-chase experiments.
Protein Expression and Purification
Escherichia coli DE3 cells were transformed with human PhLP1 in the pET15b vector or
PDCD5 in the pETDuet vector. The recombinant proteins were then purified using Co2+ affinity
chromatography as previously described for Ni2+-chelate chromatography (79). The purified
proteins were concentrated and exchanged into 20 mM HEPES pH 7.2, 150 mM NaCl by
ultrafiltration and were stored in 40% glycerol at − 20°C. Protein concentrations were
determined using BCA protein assay reagent (Pierce). CCT was purified from bovine testis as
described previously (14).
Immunoprecipitation experiments
Transfected or untreated HEK-293T or U2OS cells were washed with phosphate-buffered
saline (PBS) and solubilized in one of the following immunoprecipitation (IP) buffers depending
on the experiment: standard IP buffer (PBS pH 7.4, 1% NP-40 (Sigma)), β-tubulin IP buffer (50
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mM Na2HPO4 pH 7.5, 150 mM NaCl, 0.1% Tween 20, 1 mM GTP), β-actin IP buffer (20 mM
HEPES pH 7.4, 50 mM KCl, 1 mM DTT, 0.2 mM CaCl2, 0.5% NP-40, 4 μM cyclohexamide, 40
mM glucose), or ATP-depletion buffer (PBS pH 7.4, 1% NP-40, 100 mM deoxy-glucose, 1 mM
azide, 5 mM EDTA). All were supplemented with 0.6 mM PMSF and 6 μl/ml protease inhibitor
cocktail (Sigma P8340). The lysates were passed through a 25-gauge needle 10 times and
centrifuged at maximum speed for 10 minutes at 4ºC in an Eppendorf microfuge. The protein
concentration for each sample was determined using the DC Protein Assay Kit II (Bio-Rad), and
equal amounts of protein were used in the subsequent immunoprecipitations. The clarified
lysates were incubated for 30 minutes at 4°C with one of the following antibodies as indicated:
3-5 μg anti-myc (clone 9E10, Enzo Life Sciences), 3-8 μg anti-CCTε antibody (clone
PK/29/23/8d, AbD Serotec), 3-6 μg anti-FLAG (clone M2, Sigma), or 0.4 μg anti-HA (clone
3F10, Roche). Next, 30 μl of Protein A/G Plus agarose slurry (Santa Cruz Biotechnology) were
added, and the mixture was incubated for 20-30 minutes at 4°C. In β-actin precipitations,
DNase I agarose beads were used to precipitate folded actin as described previously (57).
Immunoprecipitated proteins and lysates were resolved on 10% or 14% Tris-glycine-SDS gels or
16.5% Tricine-SDS gels. The proteins were transferred to nitrocellulose and immunoblotted
using the following antibodies as indicated: anti-CCTα, β, δ, ε, η, θ (AbD Serotec), anti-CCTζ
(Santa Cruz), anti-CCTγ, α-tubulin, β-tubulin, PDCD5 (Abcam), anti-FLAG or anti-myc
antibodies. Immunoblots were incubated with the appropriate anti-mouse, anti-rat, anti-rabbit, or
anti-goat secondary antibody conjugated to an infrared dye (LI-COR Biosciences). Blots were
scanned using an Odyssey Infrared Imaging System (LI-COR Biosciences), and protein band
intensities were quantified using the Odyssey software. In all cases, the ratio of the co-
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immunoprecipitated protein to the immunoprecipitated protein was calculated and then
normalizing to the control.
RNA interference experiments
HEK-293T cells were grown in 12-well or 6-well plates to 40–50% confluency at which
point they were transfected with CCTζ (Dharmacon), PDCD5 (Ambion), or negative control #1
(Ambion) siRNA using Oligofectamine (Invitrogen) reagent as described previously (64) or
RNAiMAX reagent (Invitrogen) according to the manufacturer’s protocol. In some cases, cells
were transfected 24 h later with 0.5 μg (12-well) or 1.0 μg (6-well) of the indicated cDNAs using
Lipofectamine 2000 according to the manufacturer’s protocol (Invitrogen). Cells were harvested
for subsequent immunoprecipitation experiments 4 days after the knockdown. A total of 10 μg of
cell lysates were immunoblotted with anti-CCTζ or anti-PDCD5 antibodies to assess the percent
knockdown.
Mass spectrometry
PhLP1 and phosducin (Pdc) binding partners were determined by transfecting their
cDNAs with C-terminal tags containing a tobacco etch virus (TEV) cleavage site followed by a
myc epitope site (PhLP1-TEV-myc). PDCD5 binding partners were identified by transfecting
U2OS cells with an N-terminally tagged FLAG-TEV-PDCD5. Empty vector transfected cells
served as a control. After 48 hours, cells were harvested and the lysates (1 mg total protein) were
immunoprecipitated with the indicated antibodies. The proteins were released from the antibodybead complex via TEV protease cleavage according to the manufacturer's protocol (Promega).
The released co-immunoprecipitates were reduced with DTT, alkylated with iodoacetamide and
digested with trypsin as described previously (135). Proteins in the co-immunoprecipitates were
identified by tandem mass spectrometry (MS/MS). When different, details for the PhLP1 and
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Pdc MS/MS analysis are indicated first followed by those from the PDCD5 analysis. MS/MS
was performed using an LTQ-Orbitrap mass spectrometer interfaced with a Waters nanoAcquity
UPLC, outfitted with a BEH C18 reversed phase column (25 cm x 75 μm i.d., 1.7 μm, 100 or
130 Å, Waters). Peptide mixtures were separated by acetonitrile gradients for 90 min or 150 min
at flow rates of 300 or 325 nL/min. MS/MS were collected with m/z window = 475–1600 or
300–2000 Da enabling monoisotopic precursor and charge selection settings. Ions with
unassigned charge state or charge state of 1 were excluded. For each MS scan the 5 or 6 most
intense ions were targeted with a dynamic exclusion of 30 s, a 20 or 10 ppm exclusion width and
a repeat count of 2 or 1. The maximum injection time for Orbitrap parent scans was 500 ms with
1 microscan and automatic gain control of 1x106. The maximum injection time for the LTQ
MS/MS was 250 ms with 1 microscan and automatic gain control of 1x104 or 3x104. The
normalized collision energy was 35%, with activation Q of 0.25 for 30 ms. Raw files were
searched against the UniprotKB human database (including variants) with Sequest, SequestHT,
and Mascot (version 2.3) using Proteome Discoverer 1.4. Database search engine parameters
were: trypsin digestion, 2 missed cleavages, b and y ion series, precursor mass tolerance of 10
ppm, fragment mass tolerance of 0.8 Da (both assuming monoisotopic peaks), and variable
cysteine carbamidomethylation and methionine oxidation. Additional processing was performed
using mspire v0.8.6.2-1-g85f741e(136). Data were transformed to a raw list of spectral counts
and filtered to only accept those with Q-value of less than 0.01 (false discovery rate of less than
1%) and protein sequences were inferred using peptide_hit_qvalues_ to_spectral_
counts_table.rb from mspire which uses QSpec (version 2) (137) with the normalize flag, which
normalizes total spectral counts per sample. Table 2 shows average QSpec normalized spectral
counts, while Table 1 shows the sum from two biological replicates without QSpec
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normalization. A separate PhLP1 vs. control analysis was performed using QSpec so that a
reasonable significance value could be provided in Table 1.
Radiolabel pulse-chase assays
For the rate of CCT association, HEK-293T cells in 6 well plates were transfected with
PDCD5-FLAG. After 48 hours, cells were washed and incubated in methionine-free DMEM
media (Mediatech Inc.) supplemented with 4 mM L-glutamine (Sigma), 0.063 g/l L-cystine
dihydrochloride (USB) and 10% dialyzed fetal bovine serum (Invitrogen) for 1 hr. The media
was discarded and the cells were pulsed with new media supplemented with 200 μCi/ml
radiolabeled L-[35S] methionine (Perkin-Elmer) for 10 min. The cells were washed and incubated
in DMEM/F-12 growth media supplemented with an extra 10 mM L-methionine (Sigma) to stop
[35S] methionine incorporation. At increasing times, CCT was immunoprecipitated and the
proteins were resolved on 10% Tris-glycine-SDS or 16.5% Tricine-SDS gels. The radiolabeled
gels were dried, exposed on a phosphor screen (GE Healthcare) and imaged on a Storm 860
phosphorimager. The band intensities were quantified using Image Quant software (GE
Healthcare) and corrected for the number of methionine residues found in each protein. The
molar ratios of nascent proteins to CCTε were then calculated. The rate data were fit to a firstorder rate equation to determine the rate constant (k), and the t1/2 for assembly or dissociation
was calculated as t1/2 = ln 2/k.
For protein folding experiments, HEK-293T cells in 12-well plates were treated with
PDCD5 siRNA and then transfected 24 hrs. later with FLAG-cofactor B (for α-tubulin folding),
FLAG-cofactor A (for β-tubulin folding), FLAG-Gβ1 and HA-Gγ2 (for Gβ folding), or nothing
(for β-actin folding). At 96 hrs, cells were treated with [35S] methionine as described above and
chased for 60 min (α and β-tubulin), 15 min (β-actin) or 30 min (Gβ). Folded protein was then
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determined by the amount of nascent, labeled protein co-immunoprecipitating with its binding
partner. Binding partners, co-factor B (TBCB) for α-tubulin, co-factor A (TBCA) for β-tubulin,
Gγ for Gβ and DNase I beads for β-actin, associate with their targets immediately after folding
by CCT. Radioactive bands were detected and the ratios of the folded protein to its binding
partner were calculated and normalized to the control siRNA.
EM and image processing
PDCD5-CCT complexes were prepared by mixing purified components in a 10:1 PDCD5
to CCT ratio. For the two-dimensional EM analysis, aliquots of the different samples (CCT,
PDCD5-CCT complex, or the immunocomplex between PDCD5, CCT and a monoclonal
antibody against CCTδ (PK/9/86b from Genway)) were applied onto carbon-coated copper grids
and stained with 2% uranyl acetate. Micrographs were taken under minimal dose conditions in a
JEOL JEM1200EXII microscope operated at 100 kV and digitized in a Zeiss SCAI scanner with
a sampling window corresponding to 3.5 Å/pixel. Individual particles were manually selected
using XMIPP (138). Image classification was performed using a free-pattern maximumlikelihood multi-reference refinement (ML2D) (139). Homogeneous populations were obtained
and averaged for a final two-dimensional characterization.
For the three-dimensional reconstruction of the PDCD5-CCT complex, aliquots of the
solution were applied to Quantifoil 2-μm holey carbon grids for 1 min, blotted for 3 s and frozen
rapidly in liquid ethane at −180 °C. Images were acquired with a defocus range of 2–3.5 μm at
1.75 Å per pixel sampling rate on an 4K x 4K Eagle CCD camera (Gatan Inc.) mounted on a FEI
Tecnai G2 FEG200 electron microscope at 200 kV with a Gatan side-entry cryo-holder. A total
of 13,100 particles (down-sampled to 3.5 Å per pixel) were selected, normalized and CTFcorrected using standard XMIPP procedures (138). Images were classified using ML2D, and the
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most representative classes were used to generate an initial 3D model using the startcsym
program from the EMAN package (140). The resulting model was subsequently refined without
imposing any symmetry. The model was filtered at 50 Å and used for 3D maximum-likelihood
classification (ML3D) with internal correction for normalization errors (141) to separate
PDCD5-bound CCT particles from the PDCD5-free ones. The selected particles with bound
PDCD5 were refined with EMAN to obtain the final model. The resolution of the reconstructions
was determined to be 25 Å by the Fourier shell correlation coefficient (FSC) 0.5 criterion
between two independent reconstructions (Figure 3-5). The density maps and atomic structures
were visualized with UCSF Chimera (142). The atomic structures were manually fitted into the
3D reconstructions.
Amino acid incorporation and photo cross-linking
Amber codon suppression technology was used to incorporate the photo-crosslinking
unnatural amino acid p-benzoyl-L-phenylalanine (BzF) into residues at the C-terminus of
PDCD5 as described previously (143). PDCD5 variants were engineered with amber codons
inserted at residues 111, 113, 115, 117, or 119 of the PDCD5 C-terminus. Five μg of each variant
cDNA were transfected into HEK- 293T cells plated on 60 mm dishes using Lipofectamine
2000, along with 5 μg of BzF tRNA and 0.5 μg of BzF tRNA synthetase cDNA. Three hours
post-transfection, the cell media was supplemented with fresh media containing BzF, bringing
the final concentration to 1 mM. Cells were then harvested in IP buffer at 40-48 hours posttransfection and clarified lysates were exposed to UV light for 4 minutes at 4°C using a 600 W
UV lamp (150 mW/cm2, Integrated Dispensing Solutions) set to half intensity at a distance of 27
cm. FLAG-PDCD5 variants or CCTε were immunoprecipitated and immunoprecipitates and
lysates were analyzed by immunoblotting. To test the effects of BzF alone on cross-linking,
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similar experiments were performed, but without transfecting the BzF tRNA or synthetase. BzF
(1 mM) was added to the cell culture media as indicated.
Results
PDCD5 forms a ternary complex with PhLP1 and CCT
To investigate possible contributions of PhLP1 to the folding of other proteins besides
Gβ, we performed an extensive proteomic analysis of PhLP1 binding partners (Table 1).
Immunoprecipitates of PhLP1 were analyzed for potential interactors by tryptic digestion and
mass spectrometric identification of the resulting peptides. Multiple peptides from all of the CCT
subunits were found in the PhLP1 sample along with Gβ1, Gβ2 and Gβ4 as expected. A
phosducin (Pdc) immunoprecipitate was also analyzed for comparison. The Pdc sample
contained peptides from the same Gβ subunits but none of the CCT subunits. These results are
Table 3-1. PDCD5 interacts with PhLP1
Control Pdc
PhLP1 Decibans*
0
0
120
52.5
0
0
69.5
30.7
0.5
0
104
164.3

Gene
CCT4
PDCL
CCT7

Uniprot
P50991
Q13371
Q99832

0

0

68.5

29.8

HSD17B4

P51659

1.5
5
0
0.6
9
1
1
0
0
0

0
0
0
0
0
0.6
0
28.3
25.3
31

140
273
38
52
288
59.6
34.75
13
13
8

209.5
381.1
17.3
75.1
359.0
83.6
15.7
3.6
3.6

CCT2
TCP1
PDCD5
CCT3
CCT8
CCT5
CCT6A
GNB2
B2R6K4
GNB4

P78371
P17987
O14737
P49368
P50990
P48643
P40227
P62879
P62873
Q9HAV0

0

1.5

5

4.7

HNRNPA2B1

P22626

Description
T-complex protein 1 subunit δ
Phosducin-like protein
T-complex protein 1 subunit η
Peroxisomal multifunctional enzyme
type 2
T-complex protein 1 subunit β
T-complex protein 1 subunit α
Programmed cell death protein 5
T-complex protein 1 subunit γ
T-complex protein 1 subunit θ
T-complex protein 1 subunit ε
T-complex protein 1 subunit ζ
G protein subunit β-2
Transducin β chain 1
G protein subunit β-4
Heterogeneous nuclear
ribonucleoproteins A2/B1

HEK293T cells were transfected with PhLP-TEV-myc or Pdc-TEV-myc for comparison. An empty vector
transfection served as a negative control. Myc immunoprecipitates were analyzed for binding partners by tandem
mass spectrometry. The table displays significant hits found in the proteomics screen. The numbers in the first
three columns indicate the normalized spectral counts for each sample. Values in the fourth column indicate the
significance of the peptide hits (*Decibans calculated from Bayes factors taken from separately run Qspec
analysis of PhLP1 vs. Control).
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consistent with previous findings that showed an interaction between PhLP1 and CCT that was
not shared with Pdc (57). Interestingly, several peptides from PDCD5 and the peroxisomal
multifunctional enzyme type 2 (HSD17B4) were also found in the PhLP1 sample, suggesting an
interaction between PhLP1 and these proteins. The apparent interaction between PhLP1 and
PDCD5 was intriguing given the proposed tumor suppressor role of PDCD5 (132), so we
decided to explore it further. To determine the specificity of the interaction, several PhLP1
isoforms were co-expressed along with PDCD5 in HEK-293T cells and interactions were
assessed by co-immunoprecipitation and immunoblotting. PDCD5 associated with PhLP1 but
not with Pdc, PhLP2A or PhLP3, confirming that a specific interaction between PhLP1 and
PDCD5 was occurring (Figure 3-1A).
To determine whether the co-immunoprecipitation of PDCD5 with PhLP1 resulted from
a direct interaction or from indirect interactions through other proteins in a common complex,
the binding of recombinant purified PhLP1 and PDCD5 was tested in vitro by coimmunoprecipitation. Surprisingly, no PDCD5 was found in the PhLP1 immunoprecipitate
whether PhLP1 was in its CK2 phosphorylated form (69) or not (Figure 3-1B). These findings
suggest that PhLP1 and PDCD5 do not interact directly, but instead associate indirectly as
components of the same complex.
Knowing that PhLP1 binds CCT, we investigated whether PDCD5 and PhLP1 were part
of the same CCT complex. We first looked at the ability of PDCD5 to bind CCT by coimmunoprecipitation. PDCD5 immunoprecipitates contained significantly more endogenous
CCTε than PhLP1 (Figure 3-1C). In a reciprocal experiment, both PDCD5 and PhLP1 were
found in a CCT immunoprecipitate (Figure 3-1C). These results suggest that PhLP1 and PDCD5
might be interacting through CCT. To investigate this possibility, we measured the effect of
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Figure 3-1. PDCD5 forms a complex with
PhLP1 and CCT. A) Binding of PDCD5 to
phosducin family members was measured by coimmunoprecipitation from HEK293T cells
transfected with PDCD5-FLAG along with myctagged phosducin family members as indicated.
After 48 hours, cells were lysed,
immunoprecipitated with an anti-myc antibody
and immunoblotted for PDCD5-FLAG. B)
Binding of purified PDCD5 to PhLP1 or CK2
phosphorylated PhLP1 was assessed by coimmunoprecipitation in vitro. Phosphorylated
PhLP1, unphosphorylated PhLP1, or no PhLP1
was incubated with PDCD5, immunoprecipitated
with a myc antibody and blotted as indicated. C)
Simultaneous binding of PDCD5 and PhLP1 was
measured by co-immunoprecipitation. HEK293T
cells were transfected with PDCD5-FLAG or
empty vector, immunoprecipitated with FLAG
and blotted for endogenous PhLP1 and CCTε
(left panel). Endogenous CCTε was also
immunoprecipitated, blotted for endogenous
PhLP1 and PDCD5-FLAG (right panel). A nontargeting myc antibody served as a negative
control. D) The effect of CCT knockdown on
PDCD5 binding to PhLP1 was measured by coimmunoprecipitation of PhLP1-myc from HEK
293T cells treated with CCTζ siRNA or a control
siRNA and later transfected with FLAG-PDCD5 and PhLP1-myc. The ratio of the PDCD5 band to the PhLP1
band was calculated and normalized to the control. Bars represent the average ± standard error of the mean
(S.E.M) from at least three experiments. Representative blots are shown below the graphs. E) Formation of a
PhLP1-PDCD5-CCT complex was demonstrated in double immunoprecipitation experiments from HEK 293T
cells transfected with PDCD5-FLAG along with PhLP1-TEV-myc or empty vector.

siRNA-mediated depletion of CCTζ on the ability of PhLP1 to co-immunoprecipitate PDCD5.
We found that an 80% depletion of CCTζ caused a corresponding decrease in the association of
PDCD5 with PhLP1 (Figure 3-1D). This finding is consistent with the idea that PhLP1 and
PDCD5 interact indirectly through the CCT complex. To confirm this result, we performed a
double co-immunoprecipitation experiment. PhLP1 with a C-terminal tag consisting of a TEV
cleavage site and a myc epitope was over-expressed along with FLAG-tagged PDCD5 in HEK293T cells. PhLP1 was immunoprecipitated and released from the antibody and beads with TEV
protease. The resulting supernatant was then subject to a second immunoprecipitation using a
FLAG antibody. CCT was found in both the first and the second immunoprecipitates,
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demonstrating that the same CCT complexes that were associated with PhLP1 were also bound
to PDCD5 (Figure 3-1E). Collectively, these data show that PDCD5 does not bind PhLP1
directly but that they interact indirectly through a ternary complex with CCT.
Functional Analysis of the PDCD5-CCT interaction
The formation of a ternary complex between PhLP1, PDCD5 and CCT suggests that
PDCD5 and PhLP1 may be functionally linked. To begin to test this possibility, we measured the
effects of over-expression and siRNA-mediated depletion of PhLP1 or PDCD5 on the binding of
the other to CCT. Surprisingly, neither over-expression nor depletion of PDCD5 had any effect
on the interaction of PhLP1 with CCT in co-immunoprecipitation experiments (Figure 3-2 A and
B). Likewise, over-expression or depletion of PhLP1 had no effect on PDCD5 binding to CCT
(Figure 3-2C and D). These results indicate that PhLP1 and PDCD5 interact with CCT
independently of each other, raising questions about the functional significance of PDCD5
binding to CCT. It does not appear that PDCD5 requires CCT and PhLP1 for folding because
PDCD5 does not have the structure of a typical CCT substrate. It is a small 125 amino acid
protein with a simple three-helical bundle fold without multiple domains or a complex folding
pattern that are common among CCT substrates (144). Furthermore, PhLP1 has profound effects
on the binding of its known substrate, Gβ, to CCT (69,95), but this was not observed with
PDCD5 (Figure 3-2). These observations suggest that PDCD5 is not a CCT substrate but
interacts with CCT for another reason. We tested this idea further by measuring the binding of
nascent PDCD5 to CCT in a pulse-chase experimental format. Normally, nascent proteins that
are CCT substrates rapidly bind to CCT upon synthesis and are released more slowly after
folding (6,69). In contrast, nascent subunits of the CCT complex or co-chaperones like PhLP1
accumulate as part of CCT complexes over time. In a pulse-chase experiment, the CCT complex
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was immunoprecipitated with an antibody to CCTε at increasing chase times after an [35S]
methionine radiolabeling pulse, and the binding of nascent interacting partners was tracked over
time (Figure 3-3A). Newly synthesized PDCD5 accumulated with the CCT complex, as did
nascent CCT subunits, such as CCTα and γ.
In contrast, nascent tubulin, a known CCT
substrate (145), was released over time.
These results show that PDCD5 is not a
CCT folding substrate, but an interacting
partner that could act as a co-chaperone or
another type of regulator of CCT function.
To explore a possible co-chaperone
function of PDCD5, we performed an
analysis of PDCD5 binding partners.
PDCD5 was immunoprecipitated in an
ATP-depletion buffer to trap CCT
substrates on the complex and potential
Figure 3-2. PhLP1 and PDCD5 bind CCT independently
of each other. PDCD5 was either over-expressed (A) or
knocked down (B), along with PhLP1-myc over-expression in
HEK 293T cells. Cell lysates were immunoprecipitated with
anti-CCTε (A) or anti-myc (B) and blotted as indicated.
PhLP1 was either over-expressed (C) or knocked down (D),
along with PDCD5-FLAG over-expression in HEK 293T
cells. Cell lysates were immunoprecipitated with anti-CCTε
(C) or anti-FLAG (D) and blotted as indicated. Bars represent
the average ± S.E.M. from at least three experiments. Cell
lysates were blotted for PDCD5-FLAG, endogenous PDCD5,
PhLP1-myc, or endogenous PhLP1 as indicated to verify the
over-expression and knockdowns. Representative blots are
shown below the graphs.
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interactors were identified by mass
spectrometry (Table 3-2). Each of the CCT
subunits was found, as were several
isoforms of β-tubulin. The interaction
between PDCD5 and β-tubulin was
confirmed by co-immunoprecipitation. βtubulin was clearly identified in PDCD5

Table 3-2. PDCD5 interacts with β-tubulin
Control
PDCD5
Decibans
Gene
1.5
225
183.9
CCT8
0
217.7
201.6
TCP1
0
169
172.4
CCT2
0
108.5
155.2
CCT5
0
99.3
150.6
PDCD5
0
98.7
149.7
CCT7
0
88.5
135.8
CCT6A
0
85.5
142.3
CCT4
5.2
32.9
64.9
TUBB
5.9
32.8
63.4
TUBB2C
5.9
32.7
60.8
TUBB4
0
31.8
90.8
CCT3
4.5
26.7
57.7
TUBB2A
1.4
15.7
53.4
TUBB6
0
3.3
7.4
FLG2
0
2.9
5.8
GNB2L1
0
2
6.8
PIP
0
1.7
4.2
TUBA4B

UniProt
P50990
P17987
P78371
P48643
O14737
Q99832
P40227
P50991
P07437
P68371
P04350
P49368
Q13885
Q9BUF5
Q5D862
P63244
P12273
Q9H853

Description
T-complex protein 1 subunit θ
T-complex protein 1 subunit α
T-complex protein 1 subunit β
T-complex protein 1 subunit ε
Programmed cell death protein 5
T-complex protein 1 subunit η
T-complex protein 1 subunit ζ
T-complex protein 1 subunit δ
Tubulin β-5 chain
Tubulin β-2C chain
Tubulin β-4 chain
T-complex protein 1 subunit γ
Tubulin β-2A chain
Tubulin β-6 chain
Filaggrin-2
G protein subunit β-2-like 1
Prolactin-inducible protein
Putative tubulin-like protein α-4B

U2OS cells were transfected with FLAG-TEV-PDCD5 or empty vector. PDCD5 immunoprecipitates were
analyzed for binding partners by tandem mass spectrometry. The table displays significant hits found in the
proteomics screen. The values in the first two columns indicate the normalized spectral counts for each sample.
Values in the third column indicate the significance of the peptide hits (Decibans calculated from Bayes factors).

immunoprecipitates while there was no specific interaction with α-tubulin (Figure 3-3B). The
fact that both PDCD5 and β-tubulin interact with CCT suggests that they may form a co-complex
on CCT. To test this possibility, we measured the effect of siRNA-mediated CCT depletion on
the PDCD5-β-tubulin interaction (Figure 3-3C). An 80% reduction in CCTζ resulted in a 50%
reduction in β-tubulin binding to PDCD5, suggesting that the PDCD5/β-tubulin interaction
occurs at least in part through a co-complex with CCT. This interaction points to a possible role
of PDCD5 in β-tubulin folding. To test this possibility, we measured the effect of PDCD5
knockdown on β-tubulin folding as well as several other known CCT substrates. To perform this
measurement, we developed a new approach to assess tubulin folding by determining the rate of
association of nascent α and β-tubulin with co-factor A (for β-tubulin) and co-factor B (for αtubulin) in a pulse-chase experimental format. These co-factors are the first to interact with their
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respective tubulins after they are folded by CCT in the process of tubulin dimer formation (146).
For comparison, we also measured the effects of PDCD5 knockdown on β-actin and Gβ folding
using previously established methods (57,64). PDCD5 knockdown increased the rate of β-tubulin

Figure 3-3. PDCD5 inhibits β-Tubulin folding. A) The rate of association or dissociation from CCT
complexes was measured by pulse-chase immunoprecipitations of CCTε from HEK 293T cells transfected with
PDCD5-FLAG. The rate of association of CCT α and γ subunits (black, t1/2 = 112 ± 18 min) and PDCD5 (red,
t1/2 = 44 ± 2 min) were calculated along with the rate of dissociation for tubulin (blue, t1/2 = 39 ± 1 min). B)
Binding of β-tubulin to PDCD5 was measured by co-immunoprecipitation from HEK 293T cells transfected
with FLAG-PDCD5 or empty vector. C) The effect of CCT knockdown on β-tubulin binding to PDCD5 was
measured by co-immunoprecipitation from HEK 293T cells treated with CCTζ siRNA or a control siRNA and
later transfected with FLAG-PDCD5. The ratio of the β-tubulin band to the PDCD5 band was calculated and
normalized to the control. D) The folding of the indicated proteins by CCT was measured by pulse-chase coimmunoprecipitations from HEK 293T cells treated with PDCD5 siRNA or negative control as indicated (see
Experimental Procedures). E-F) The effect of PDCD5 knockdown (E) or over-expression (F) on β-tubulin
binding to CCT was measured by co-immunoprecipitation with CCTε and immunoblotting as indicated. The
ratio of the β-tubulin band to the CCTε band was calculated and normalized to the control. In all experiments,
bars represent the average ± S.E.M. from at least three experiments. Representative gels or blots are shown
below each graph. PDCD5 knockdown averaged between 65 and 80% as measured by immunoblotting.
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folding by more than 50%, while it had no effect on α-tubulin, β-actin or Gβ folding (Figure 33D). These findings are consistent with the binding of PDCD5 and β-tubulin to CCT and indicate
that PDCD5 interacts with CCT to specifically down regulate β-tubulin folding.
To further investigate the mechanism by which PDCD5 inhibited β-tubulin folding, we
measured the effects of PDCD5 knockdown and over-expression on the binding of β-tubulin to
CCT. An 80% siRNA reduction of PDCD5 increased the binding of β-tubulin to CCT by 35%
(Figure 3-3E), while PDCD5 over-expression decreased the binding of β-tubulin to CCT by 40%
(Figure 3-3F). In contrast, the binding of α-tubulin to CCT was unaffected by these changes in
PDCD5 expression. Together, these findings indicate that PDCD5 specifically inhibits β-tubulin
folding by disrupting the interaction of β-tubulin with CCT. This result was unexpected in light
of the data from Figure 3-3B and 3-3C, showing that PDCD5 and β-tubulin form a complex with
CCT. However, these observations can be reconciled if PDCD5 only partially inhibits β-tubulin
binding to CCT (see Discussion).
Structural analysis of the PDCD5-CCT interaction
To begin to understand how PDCD5 might disrupt the interaction of β-tubulin with CCT,
we performed a structural analysis of the PDCD5-CCT complex. An excess of purified PDCD5
was combined with purified CCT in vitro in the absence of nucleotide. The resulting complex
was subjected to native gel electrophoresis after which the high molecular weight band
corresponding to the CCT complex was excised and resolved on a denaturing gel. The
denaturing gel showed the bands corresponding to the eight CCT subunits and a band
corresponding to PDCD5, indicating the formation of a stable PDCD5-CCT complex (Figure 34A). The existence of the PDCD5-CCT complex was confirmed by electron microscopy (EM).
Negatively stained EM images showed the typical doughnut-shaped structure corresponding to
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end-on views of CCT (Figure 3-4B). Most of the particles revealed a small, elongated mass
protruding into the CCT cavity. This mass was clearly observed upon processing and averaging
of 1354 of these particles (Figure 3-4B), but was not present in the average image of 1128
PDCD5-free CCT particles (Figure 3-4C), thus the mass is attributable to PDCD5. The PDCD5
protruded from only one of the eight CCT subunits. To identify this CCT subunit, we employed
an immuno-microscopy approach. A monoclonal antibody against CCTδ labeled the CCT
subunit very near the PDCD5 mass, suggesting that PDCD5 binds CCTδ or an adjacent subunit
(Figure 3-4D).
To determine its threedimensional structure, the PDCD5-CCT
complex was frozen-hydrated and
subjected to cryo-EM. A threedimensional reconstruction carried out
with 13,000 particles to 25 Å resolution
(Figure 3-5) revealed the typical barrelshape structure built by the two
octameric CCT rings in an open,
Figure 3-4. PDCD5 binds CCT near the δ subunit. A) Gel
analysis of the PDCD5-CCT complex. PDCD5 was mixed
with CCT at a 10:1 molar ratio in the absence of nucleotide
and the mixture was resolved on a native polyacrylamide gel.
The CCT oligomer (~960 kDa), which runs with a mobility
clearly distinct from that of PDCD5 (~14 kDa), was excised
and run on a denaturing acrylamide gel revealing bands
corresponding to the eight CCT subunits and a band
corresponding to PDCD5. B-D) Average electron microscopy
images obtained from negatively stained particles. (B)
PDCD5-CCT, (C) apo-CCT, (D) anti-CCTδ-PDCD5. Images
were averaged from 1356, 1128 and 1018 particles,
respectively.
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substrate-receptive conformation, as is
the case with CCT in the absence of
nucleotide (Figure 3-6). The
reconstruction clearly shows a small
mass, attributable to PDCD5, protruding
from one of the CCT subunits. Although

the PDCD5 mass points toward the
interior of CCT, it does not enter into
the folding cavity but rather extends
above it in a position not observed with
CCT substrates actin and tubulin. A
docking analysis using the 5.5 Å crystal
structure of CCT in its open
conformation (7) and an NMR solution
structure of a PDCD5 fragment
containing all but the last 12 residues of
the C-terminus (144) gave a good fit
into the cryo-EM three-dimensional
Figure 3-5. Three-dimensional reconstruction of the
PDCD5-CCT complex. (A) Representative area of a
micrograph of a vitrified sample of PDCD5-CCT complexes.
Green circles show end-on views of the complex, whereas red
rectangles mark side views. (B) Gallery of selected images of
PDCD5-CCT complexes. (C) Average images corresponding
to different classes used for the generation of the first volume.
(D) Selected projection views (top) and the corresponding
class averages (bottom) of the final model. (E) Fourier shell
correlation (FSC) plot of the PDCD5-CCT reconstruction
showing 25 Å resolution at a 0.5 FSC value.

reconstruction (Figure 3-6B). The facts
that the mass attributed to PDCD5
accommodates the native atomic
structure of the protein and that this
mass is positioned on top of the folding

cavity reinforce the idea that PDCD5 is not a substrate of CCT but rather may have a regulatory
function.
The docking of the PDCD5 atomic structure was best when the C-terminus was oriented
toward the CCT subunit (Figure 3-6B). To determine if the C-terminus of PDCD5 was involved
in the interaction, the effects of several C-terminal truncations on PDCD5 binding to CCT were
measured (Figure 3-6C). Near normal binding was observed for truncations up to the last nine
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residues (PDCD5 ∆117-125). However,
further truncation (PDCD5 ∆115-125)
resulted in a complete loss of binding.
Thus, it is clear that the PDCD5 Cterminus participates in contacts with
CCT, supporting the docking orientation
shown in Figure 3-6B.
Chemical cross-linking of PDCD5 to
CCT
The immuno-EM showed that
PDCD5 was associated with CCTδ or an
adjacent subunit. We sought to identify
precisely which CCT subunit is involved
Figure 3-6. PDCD5 binds the apical domain of one CCT
subunit. A) Two orthogonal views of the three-dimensional
reconstruction of the PDCD5-CCT complex carried out with
13,000 particles at 25 Å resolution. B) The same two views
showing the docking of the crystal structure of the open form
of CCT colored by subunit (2XSM) and the atomic structure
of PDCD5 in green (2K6B). C) Binding of various Cterminal truncations of PDCD5 to CCT was measured by coimmunoprecipitation and immunoblotting.

by employing amber codon suppression
technology to incorporate the photocrosslinking unnatural amino acid pbenzoyl-L-phenylalanine (BzF) into
residues at the C-terminus of PDCD5

and specifically cross-link the CCT subunit in close proximity to these residues (143). We
engineered amber codons (TAG) at positions 115, 117 or 119 of the PDCD5 cDNA and
transfected these variants into HEK-293 cells along with the BzF tRNA and BzF tRNA
synthetase. Cells were subsequently incubated with BzF, and cell extracts were cross-linked with
ultraviolet (UV) light (Figure 3-7A). PDCD5 was immunoprecipitated and immunoblotted to
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Figure 3-7. Unnatural amino acid
incorporation into PDCD5. A) Scheme
of unnatural amino acid UV crosslinking
using benzoylphenylalanine (BzF). B)
BzF incorporation into Amber codon
variants of PDCD5 and the G protein β
subunit. HEK 293T cells were transfected
with the indicated FLAG-PDCD5
constructs, BzF tRNA, and BzF AA
synthetase and treated with 1 mM BzF 3
hrs. post transfection. Lysates were
immunoblotting to determine the level of
expression of the variants. The percent
incorporation was measured as the ratio of
the truncated protein band, resulting from
a lack of BzF incorporation into the
Amber codon, to the full-length protein
band, resulting from BzF incorporation
into the Amber codon. PDCD5 averaged
6% incorporation compared to 75% for
Gβ1.

detect potential
PDCD5 cross-links.
Unfortunately,
incorporation of BzF
into PDCD5 was
unusually low, less
than 10% as judged
by the intensity of the
full-length, BzFincorporated PDCD5

band in immunoblots of cell lysates compared to the truncated PDCD5 band resulting from failed
incorporation (Figure 3-7B). In contrast, ~75% BzF incorporation was common for Gβ using this
same method (Figure 3-7B). Despite the low degree of BzF incorporation, UV-induced PDCD5
cross-links were still observed but not as expected (Figure 3-8A). Surprisingly, we could detect a
strong UV-dependent PDCD5 cross-link at ~75 kDa in the control sample, transfected with wildtype PDCD5 that had no amber codon incorporation site. This cross-link was also seen in the
variants with amber codons at residues 117 and 119 producing the ∆117-125 and ∆119-125
truncations that retained binding to CCT, but the cross-link was greatly reduced in the residue
115 variant producing the ∆115-125 truncation that had lost binding to CCT. This unexpected
result indicates that UV irradiation induced a PDCD5 cross-link independent of incorporation of
BzF into the amber codon site.
Two observations suggested that the observed PDCD5 cross-link was to a CCT subunit.
First, the cross-linking efficiency corresponded closely to the ability of the wild-type or truncated
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PDCD5 variants to bind CCT (compare Figure 3-6C and Figure 3-8A). Second, the ~75 kDa size
of the cross-link was approximately equal to the sum of the ~60 kDa mass of a CCT subunit and
the 16 kDa mass of FLAG-tagged PDCD5. To further explore this possibility and to determine
which CCT subunit might be involved, the cross-linked PDCD5 immunoprecipitates were
immunoblotted for all eight CCT subunits. The ~75 kDa cross-link in the WT PDCD5 sample
was detected only in the CCTβ immunoblot (Figure 3-8B). Furthermore, the CCTβ cross-link
was also found only in immunoprecipitates of the WT, ∆117-125 and ∆119-125 PDCD5 variants
that bound CCT and not with the ∆115-125 variants that did not bind CCT (Figure 3-8C). These
results clearly show that PDCD5 was specifically cross-linked to CCTβ. Given that UV-induced
cross-links are short lived and occur over distances of ~3 Å (143), PDCD5 must be in close
proximity to CCTβ. This finding is consistent with the immuno-EM images showing that
PDCD5 bound near CCTδ because in the recently revised orientation of the subunits within the
CCT complex, CCTβ is adjacent to CCTδ (147,148).
From these results, it is not obvious how the UV-induced cross-linking of PDCD5 to
CCTβ occurs, but the cross-linking was dependent on BzF and was independent of the BzF
tRNA or synthetase. In cells not transfected with the BzF tRNA or synthetase, a robust PDCD5CCTβ cross-link was observed in the presence of BzF, but not in its absence (Figure 3-8D).
Thus, the free BzF in the cell extract must be catalyzing the cross-linking reaction. An
examination of the free radical chemistry of BzF suggests possible ways that free BzF could
cross-link two proteins. UV-light initiates a BzF diradical intermediate that then removes a
hydrogen from an adjacent protein, creating an alkyl radical on the protein and a ketyl radical on
the BzF. Normally, the two radicals then recombine to yield a benzhydrol modification of the
protein (149). However in this case, a sufficient amount of the alkyl radical formed on either
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PDCD5 or CCTβ must react with its binding partner to form a detectible inter-protein cross-link.
This unusual radical chemistry confirms a close binding interaction between PDCD5 and CCTβ.

Figure 3-8. PDCD5 interacts directly with CCTβ. A) Cross-linking of PDCD5 to CCT. HEK 293T cells were
transfected with the indicated FLAG-PDCD5 constructs, BzF tRNA, and BzF AA synthetase and treated with 1
mM BzF 3 hrs. post transfection. Lysates were exposed ± UV prior to immunoprecipitation and blotting for
FLAG-PDCD5. The asterisk indicates a PDCD5 cross-linked band. HC – heavy chain. B) Cross-linking of PDCD5
to the CCT subunits was measured by co-immunoprecipitation from HEK 293T cells treated as in panel A and
exposed to UV prior to immunoprecipitation with a CCTε antibody and blotting for each of the CCT subunits. The
asterisk indicates a CCTβ cross-linked band. The arrows mark the position of the CCT subunits. NS – non-specific
band. C) PDCD5 cross-linking to CCTβ depends on an interaction with the PDCD5 C-terminus. HEK 293T cells
were treated as in panel A and lysates were exposed ± UV prior to immunoprecipitation with a CCTε antibody and
blotting for CCTβ. The asterisk indicates a CCTβ cross-linked band. D) BzF catalyzes PDCD5 cross-linking to
CCT without incorporation into Amber codon sites. HEK 293T cells were transfected with FLAG-PDCD5 (WT) in
the absence of BzF tRNA and BzF AA synthetase. Cells were treated ± 1 mM BzF 3 hrs. post transfection. Lysates
were exposed ± UV prior to immunoprecipitation with CCTε and immunoblotting for CCTβ. The asterisk indicates
a CCTβ cross-linked band.
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Discussion
Our search for novel PhLP1 binding partners has led to the serendipitous finding that the
pro-apoptotic protein PDCD5 interacts with CCT. Investigation of the physiological role of the
PDCD5-CCT interaction suggests that PDCD5 acts as a regulator of CCT function. The
significant increase in β-tubulin folding upon PDCD5 depletion points to an inhibitory role for
PDCD5 in β-tubulin folding (Figure 3-3D). This inhibition was specific for β-tubulin and was
not shared with other CCT substrates α-tubulin, β-actin and Gβ. Accordingly, PDCD5 interfered
with the binding of β-tubulin to CCT but not α-tubulin, indicating that PDCD5 specifically
blocked β-tubulin folding by disrupting its interaction with CCT (Figure 3-3E and F). This
disruption could result from a number of factors, but steric overlap of the binding sites of
PDCD5 and β-tubulin on CCTβ seems likely. The cryo-EM reconstruction and cross-linking
identifies an interaction of PDCD5 with the CCTβ helical protrusion at the tip of the apical
domain (Figs. 3-4–3-8), and the crystal structure of the β-tubulin-CCT complex shows contacts
between β-tubulin and the helical protrusion of CCTβ (7). A second β-tubulin contact site was
also observed deeper within the CCT folding cavity, contacting the sensor loop of the equatorial
domain (7). Thus, PDCD5 could interfere with β-tubulin binding in the helical protrusion
without affecting its interaction with the sensor loop. Such partial inhibition is consistent with
the observed effects of PDCD5 on β-tubulin binding to CCT and on β-tubulin folding (Figure
3-3).
The ability of PDCD5 to discriminate between α and β-tubulin was unexpected. The two
proteins are structurally comparable and both interact similarly with CCT (7,10), yet PDCD5
only binds the β-tubulin-CCT complex and only inhibits β-tubulin folding (Figure 3-3). It
appears that when α-tubulin is bound to CCT, PDCD5 is excluded and has no effect on α-tubulin
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folding. The source of this specificity is unknown, but could result from PDCD5 disrupting CCT
contacts specific to β-tubulin, or from a direct interaction between PDCD5 and β-tubulin. The
residual binding of β-tubulin to PDCD5 upon CCT knockdown suggests that direct interactions
between PDCD5 and β-tubulin do exist (Figure 3-3C).
PDCD5 has been proposed to act as a pro-apoptotic factor with tumor suppressor
capabilities (132). However, the molecular mechanisms underlying its apoptotic function are
largely unknown. Interactions between PDCD5 and two pro-apoptotic proteins, the histone
acetyl transferase Tip60 (133) as well as the transcription factor p53 (134) have been proposed to
contribute to its apoptotic role. A key question arising from our studies is what contribution
PDCD5 binding to CCT and inhibition of β-tubulin folding contributes to PDCD5-mediated
apoptosis. Interestingly, the C-terminal truncations of PDCD5 that were found to disrupt its
interaction with CCT (Figure 3-6C) have been reported previously to be less effective in
inducing cellular apoptosis (144). This correlation suggests that CCT binding and inhibition of βtubulin folding could contribute to the apoptotic function of PDCD5. Tubulin dimer formation is
a complex process, involving multiple co-factors that bring α- and β-tubulin together after their
release from CCT (146). The process is vital for cell function in providing the building blocks
for the microtubules that make the mitotic spindle and other important cellular structures. If
mitotic spindle formation is disrupted, cells cannot divide and will eventually die, thus the large
number of anti-cancer drugs that disrupt microtubule dynamics (150). PDCD5-mediated
inhibition of β-tubulin folding could disrupt tubulin dimer formation and microtubule assembly
and thus contribute to apoptosis.
The image emerging from this work and other previous studies shows CCT decorated
with co-chaperones and regulators that modulate its protein folding function. For example,
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prefoldin delivers actin and tubulin to CCT for folding (17). PhLP1 allows release of Gβ from
CCT to associate with Gγ and form the Gβγ dimer (64), and now PDCD5 binds CCT to slow βtubulin folding and possibly disrupt microtubule formation. By employing co-chaperones in this
manner, CCT is able to expand and fine-tune its already versatile protein folding capacity.
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